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INTRODUCTION
Allergy is an important disease that affects a substantial proportion of the general
population, and which has seen an increasing incidence during the past three
decades. In the first years of life, the immune system is relatively immature and
highly susceptible for the development of sensitization and allergy to
environmental allergens such as foods and inhalants. This thesis focuses on allergy
to cow’s milk, one of the major food allergens during infancy and early childhood.
Special attention will be paid to the role of antigen-specific T cell reactivity in the
aetiology of cow’s milk allergy (CMA).
ATOPY AND THE ALLERGIC MARCH
Atopy comes from the Greek ‘atopos’ which means ‘out of place’. Persons with
atopy have a hereditary predisposition to respond with allergic reactions against
environmental antigens such as food- and inhalation-allergens. Immunologically,
atopy expresses itself as sensitization; i.e. the development of allergen-specific IgE,
which can be detected in the blood of atopic individuals1. Clinically, atopy is
expressed through allergic conditions which tend to cluster in families, including
atopic dermatitis (AD), allergic asthma and allergic rhinitis2-4. These three diseases
together make up the ‘atopic syndrome’.
The natural history of atopic diseases is characterized by a typical sequence of
sensitization and manifestation of symptoms which appear during a certain age
period. This is often called the ‘allergic march’5,6. The symptoms can persist over
years or decades, and often show a tendency for spontaneous remission with age.
Usually, the ‘allergic march’ starts with the development of AD during the first 3-4
years of life7. This is commonly followed by the development of allergic asthma
around the age of 4-5 years8,9. In the subsequent years, allergic rhinitis develops,
which usually persists into adulthood10. The presentation of the different symptoms
mostly overlap. Figure 1 shows a schematic representation of the incidence, and
time of occurrence of the different symptoms11.
ATOPIC DERMATITIS
Atopic dermatitis is a chronic eczematous skin disease which is characterized by a
course of remissions and exacerbations12. Typical for AD are the pruritic,
erythematous lesions with lichenification and thickening of the skin13. The
diagnosis of AD is made on clinical grounds according to the criteria of Hanifin
and & Rajka12,14. These criteria are based on the patient’s history, family history
and distinct clinical morphology and distribution of skin lesions.
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AD is usually the first clinical presentation of the atopic state of an individual, and
has an onset during infancy or early childhood7. It is estimated that 60% of the
individuals who will develop AD, already have symptoms during the first year of
life, and 85% during the first 5 years of life15. Overall, more than 10% of all
children have AD at some point during childhood16.
The relation between AD and allergic (atopic) disease is established through both
clinical and immunological observations17,18. Clinically, patients with AD and
allergy can experience a deterioration of their dermatitis after contact with
allergens7. These contacts may also lead to acute cutaneous symptoms such as
erythema and urticaria19. Immunologically, patients with AD generally have
increased levels of IgE specific for common environmental allergens such as food
and inhalation allergens15. While sensitization to food allergens is commonly found
in infants with AD, inhalation allergens are more important in older children and
adults with AD20,21. The allergen-specific IgE responses can be demonstrated in
blood, but also in skin, by using allergen-specific test methods such as the skin-
prick test22,23.
COW’S MILK ALLERGY
Cow’s milk is usually the first food antigen that is introduced into an infant’s diet,
and CMA is often the first presentation of the atopic state of an individual24.
Ingestion of cow's milk leads to allergic reactions in approximately 2-3% of all
infants, and individuals with an atopic predisposition have an increased risk of
Figure 1. Schematic representation of the natural course of atopic disease in childhood
(‘allergic march’), adapted from reference 11.
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developing CMA25-28.
The most common symptom of CMA in childhood is AD28,29. It is estimated that
CMA plays a pathogenic role in approximately 35-40% of infants with AD in the
first year of life30-32. In these infants, ingestion of cow's milk leads to acute
(‘immediate-type’) cutaneous symptoms in combination with aggravation of the
eczema29. Besides cutaneous symptoms, CMA can also lead to immediate-type
pulmonary and/or gastro-intestinal symptoms, or even systemic anaphylaxis24. It
has been suggested that patients with CMA can also experience isolated ‘late’ or
‘delayed-type’ reactions. These are allergic reactions which are said to arise more
than 24 hours after intake of cow’s milk, and concern non-life-threatening
symptoms such as infantile colic syndrome33,34. The existence of these isolated,
delayed-type reactions however, has not yet been indisputably demonstrated in
double-blinded test settings35,36.
The diagnostic work-up of infants and children with suspicion of CMA is a multi-
step process involving both in vitro and in vivo methods35,37. After a suspicion of
CMA is established by careful examination of the medical history, and by physical
examination, the first step is to investigate the presence of cow’s milk specific
sensitization, by using cow’s milk-specific IgE-detection and/or SPT. The presence
of cow’s milk-specific sensitization indicates an immune reaction to milk, but does
however not necessary mean clinical allergy. To prove clinical significant CMA, a
provocation with milk is needed, preferably performed by using a double-blind,
placebo-controlled food challenge (DBPCFC), as this is the most objective method
to diagnose milk-induced symptoms37,38.
In contrast to other food allergies, CMA in infancy is associated with the
spontaneous development of clinical tolerance during early childhood. Prospective
studies have shown that tolerance to cow’s milk develops in more than 85% of the
infants with CMA before the age of 3 years25,26,39. However, a small part of the
patients retain their allergy until adolescence (persistent CMA)40, and sometimes
even into the second decade41. The mechanisms that determine the spontaneous
development of clinical tolerance in patients with allergy to cow’s milk are still
under investigation.
THE IGE-RESPONSE TO COW’S MILK-PROTEINS
Allergen-specific IgE antibodies have been shown to be important in the aetiology
of allergic reactions via their role in the degranulation of mast cells and basophilic
granulocytes, but also through their accessory function in the presentation of
allergens42-44.
The protein-fraction of cow’s milk is the major immunogenic component, and
consists of at least 20 proteins that may provoke an antibody response in man28,45-47.
The whey proteins, α-lactalbumin and β-lactoglobulin, together with the casein-
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proteins, are proposed to be the most important allergenic proteins, and the IgE-
response to these proteins has been well investigated in infants and children48-50.
A recent study, that investigated the natural course of sensitization to cow’s milk
allergens in a large population-based sample, estimated that the prevalence of IgE
antibodies to cow’s milk in an unselected population is approximately 6% at the
age of 1 year51. It is clear however, that infants with an atopic predisposition have a
greater risk of the development of IgE antibodies to cow’s milk proteins (CMPs)
than non-atopic infants20,52,53. In addition, the levels of CMP-specific IgE are
generally higher in children with atopy compared with non-atopic children, who
show mostly transient sensitization for cow’s milk20,21,54-56. Interestingly, the
kinetics of IgE responses to cow’s milk, as well as other foods, differ significantly
from the response to inhalant allergens such as house dust mite and pollen (Figure
2). While cow’s milk-specific IgE can be detected in most atopic individuals
shortly after birth, and rarely persists after early childhood, inhalant allergen-
specific IgE only rarely appears before the age of 1 year, and usually persists into
adulthood20,21. These differences most probably reflect the differences in timing
and amount of exposure to these allergens53,57.
The presence of CMP-specific IgE does not necessarily implicate clinically
relevant CMA37. Studies have shown that only 30-40% of the individuals with
CMP-specific IgE experience clinical symptoms after ingestion of cow’s milk58,59.
Figure 2.  Postnatal IgE-responses to environmental allergens in normal and atopic
children, derived from data in references 20 and 21. Curves are exemplary of the types of
time-dependent changes seen in antibody levels of individual children; curves for atopic
children all fall within the shaded area and those for normals are restricted to the clear
areas. Asterisk represents cut-off level of commercially available assays.
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This means that, while IgE is important for the initiation of allergic responses,
other presently unknown (but probably tissue-related) mechanisms prevent clinical
relevant allergic disease in most individuals with CMP-specific IgE. Studies who
investigated the levels of CMP-specific IgE in patients with clinically relevant
CMA, showed that the spontaneous development of clinical tolerance for cow's
milk is usually associated with a downregulation of the IgE-response60-63. However,
in most tolerant patients, low-level IgE responses to cow’s milk proteins continue
to occur37, which emphasizes that the presence of CMP-specific IgE alone does not
determine allergy or tolerance to cow’s milk.
T CELLS AND ATOPIC DISEASES
T cell responses to allergens have been shown to be important in the aetiology of
atopic diseases1,17,64,65. CD4+ T helper (Th) cells are generally subdivided into
‘Th1’ and ‘Th2’ cells66-68. Th1 cells are defined as T cells that predominantly
produce interferon (IFN)-γ, interleukin (IL)-2, and tumor necrosis factor-β, while
Th2 cells are T cells that produce predominantly IL-4, IL-5, and IL-1369,70. Both
cell-types have been associated with specific immunoregulatory functions71. Th1
cells evoke cell-mediated immunity and phagocyte-dependent inflammation69,
while Th2 cells mediate strong antibody responses, including those of the IgE-
class72, and eosinophil accumulation73. Although there seems to be a predominance
of some T cell subsets in certain disease-states, numerous studies have shown that
human T cells generally produce a heterogeneous cytokine profile69,74. These cells,
which can produce equal amounts of both ‘type-1’ and ‘type-2’ cytokines are often
called ‘Th0’ cells69,70.
Investigations have shown a crucial role for allergen-specific CD4+ Th2 cells in
the aetiology of atopic diseases such as AD17,18,65,75. Studies that investigated the
systemic T cell response in patients with house-dust mite allergy and AD, showed
that allergen-specific T cells in blood of allergic individuals generally display a
Th2-pattern; i.e. high production of IL-4, IL-5 and IL-13, and little or no IFN-γ76-78.
It was shown that these allergen-specific Th2 cells can infiltrate into the skin, and
initiate an allergic skin-response by stimulation of IgE synthesis and eosinophil
recruitment18,64,79,80. Subsequently, the T cell response in the skin switches to a
response dominated by Th1-cytokines64,81,82, which eventually results in the chronic
skin lesions that are characteristic of AD18.
The process by which circulating allergen-specific T cells extravasate and
subsequently migrate to the skin is thought to be mediated by the expression of
cutaneous lymphocyte antigen (CLA) 83-85. It is proposed that CLA expression is
the imperative signal for a T cell to selectively migrate to the skin, after which
allergic skin inflammation is initiated by Th2 cytokine release17,75,86,87. Evidence for
these mechanisms have so far primarily been investigated for inhalation allergens
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such as house-dust mite and pollen. The role of food-specific T cell reactivity in
the aetiology of food-induced skin symptoms is not yet clarified.
T CELL REACTIVITY AND CMA
There is evidence that cow’s milk-specific T cell reactivity may play an important
role in the aetiology of CMA, and cow’s milk-induced symptoms. Cow’s milk-
reactive T cells in peripheral blood mononuclear cells (PBMCs) from cow’s milk-
allergic patients have been shown to proliferate in the presence of cow’s milk
proteins88-100. This demonstrates that T cells, specific for the proteins in cow’s milk,
are present in blood of patients with allergy to cow’s milk. Studies that investigated
the nature of these proliferative PBMC responses, suggested that CMP-specific T
cells from allergic patients have an enhanced activated state, with high proliferative
capacity88-91,93-97,99.
Investigations that determined cytokine release by CMP-stimulated PBMCs
showed high levels of IL-4 (Th2 cytokine), and lower levels of IFN-γ (Th1
cytokine)92,98,100. These results may suggest that the T cell response in cow’s milk
allergic patients is Th2-biased. Because of the relevance of allergen-specific Th2
cells in inhalation allergy64,65, it could be speculated that CMP-specific T cells play
a similar role in the aetiology of CMA. So far, however, studies into CMP-specific
T cell reactivity and cytokine release have been mainly performed using bulk-
cultures of T cells. A disadvantage of this is, that the observed reactivity and/or
cytokine production is the sum of a polyclonal T cell response, with different
antigen-specificities and different individual cytokine profiles. Results from
previous studies in PBMCs therefore need to be verified by investigations at the
clonal level.
More importantly, a well designed study comparing CMP-specific T cell reactivity
in cow’s milk allergic patients with age-matched atopic and non-atopic controls
patients has not yet been performed. Although atopic individuals are prone to
develop sensitization and allergy to cow’s milk, not all atopic individuals do
develop CMA. Investigations into the possible differences in T cell reactivity
between atopic individuals with and without CMA should therefore be performed.
A remarkable feature of CMA is that, in contrast to other (food) allergies, it is
associated with the spontaneous development of clinical tolerance during early
childhood. This process has not yet been studied at the T cell level. It is presently
unclear if clinical tolerance after CMA is associated with a downregulated T cell
response to CMPs (immunological tolerance). If this is the case, this would imply
that the CMP-specific T cells have been deleted from the T cell repertoire, or have
been anergized. It could also be that T cell reactivity to CMPs is still present after
the development of tolerance, but has been modulated, for instance with regard to
production of cytokines.
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AIM AND OUTLINE OF THIS THESIS
The aim of this thesis was to investigate the role of antigen-specific T cells in
cow’s milk allergic infants. Furthermore, the currently used methods to diagnose
CMA, in vivo and in vitro, were evaluated.
The major research questions addressed in this thesis are:
- Do CMP-specific T cells in patients with allergy to cow’s milk differ from CMP-
specific T cells from individuals without CMA, with regard to specificity for the
different proteins in cow’s milk, production of cytokines, and expression of cell-
surface markers?
- Is the CMP-specific T cell response from children that have spontaneously
developed clinical tolerance to cow’s milk, different from the CMP-specific T
cell response during the allergic state?
- Are there differences between CMP-specific T cells in blood and skin of patients
with CMA and allergic skin symptoms?
- Is in vitro IgE detection and/or skin prick testing sufficient to screen for cow’s
milk-specific sensitization?
- Can double-blinded cow’s milk challenges be used in common clinical practice?
The role of cow’s milk-specific T cells in the aetiology of CMA is described in
Chapter 2-6. In Chapter 2, differences between the cow’s milk-specific T cell
response in infants with AD with and without CMA are examined, with emphasis
on the production of Th1- and Th2-cytokines. Chapter 3 describes the presence and
phenotype of CMP-specific T cells in blood of non-atopic infants without CMA. In
Chapter 4, the changes that occur in the cow’s milk-specific T cell response during
the spontaneous development of tolerance for cow’ milk in infants with CMA and
AD are investigated. Chapter 5 provides a description of the differences between
expression of cell-surface markers by cow’s milk-specific T cells from infants with
and without CMA, and the changes in expression of these markers during the
spontaneous development of tolerance for cow’s milk. In Chapter 6, cow’s milk-
specific T cells from blood and skin are investigated, and compared with regard to
expression of the skin-specific cell-surface marker, cutaneous lymphocyte antigen.
The currently used methods to diagnose CMA are studied in Chapter 7-8. Chapter
7 evaluates the screening for food-specific sensitization using in vitro IgE detection
and skin prick testing, in infants and children referred for suspicion of food allergy.
Chapter 8 provides a description of a new protocol for a double-blind, placebo-
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controlled cow’s milk challenge for infants and children with suspicion of CMA.
Chapter 9 is a general discussion about the relevance of all presented data on CMP-
specific T cells. In this chapter, a model is presented that describes the
development of the CMP-specific T cell response during infancy and early
childhood.
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ABSTRACT
Background Cow's milk is the most important food antigen in infancy, and may
lead to acute cutaneous symptoms and atopic dermatitis (AD). The role of
circulating allergen-specific T cells in the pathogenesis of food-allergic skin
symptoms is still under investigation.
Objective This study was designed to analyze the cow's milk protein (CMP)-
specific T cell response at the clonal level in infants with AD and cow's milk
allergy (CMA), in comparison to infants with AD without CMA.
Methods We used an antigen-specific culturing system with autologous B
cells as antigen-presenting cells to establish CMP-specific T cell clones, derived
from peripheral blood mononuclear cells, in infants with AD. T cell reactivity,
measured by lymphocyte stimulation test, and cytokine production, measured by
ELISA, was compared between infants with AD, with and without CMA.
Results Both infants with, and without allergy to cow's milk had a CMP-
specific T helper cell response directed against the major proteins in milk. Analysis
of antigen-specific cytokine production showed that this response was Th2-skewed
in infants with CMA, with production of high levels of interleukin (IL)-4, IL-5 and
IL-13. In contrast, infants without CMA had a Th1-skewed response, with high
levels of interferon-γ (IFN-γ) and low levels of IL-4, IL-5 and IL-13.
Conclusion These data confirm for the first time at the clonal level, that food
allergy in infants with AD is associated with production of Th2 cytokines by
circulating antigen-specific CD4+ T cells, while tolerance to food antigens is
associated with low levels of these cytokines. This suggests a key role for the T
helper cell-derived Th2 cytokines in food allergy-related skin symptoms.
INTRODUCTION
Atopic dermatitis (AD) is a chronic eczematous skin disease with early onset in
infancy, characterized by a course of remissions and exacerbations1. At present, the
pathogenesis of AD is not fully understood. In patients with AD and allergy
towards inhalation-allergens such as house dust mite, circulating allergen-specific
Th2 cells have shown to be important in the pathogenesis of allergic skin
symptoms2-4. The infiltration into the skin of these T cells which produce high
levels of interleukin (IL)-4, IL-5 and IL-13, but little or no interferon-γ (IFN-γ)5,6,
can mediate allergic skin inflammation through stimulation of IgE synthesis and
eosinophil recruitment7.
Cytokine release by T cells
25
Evidence for these mechanisms in food-allergy are much less well established.
Food-reactive T cells in peripheral blood mononuclear cells (PBMCs) from food-
allergic patients with AD have been shown to proliferate in the presence of food
antigens8,9. This capacity is however not restricted to the food-allergic patient, as
PBMCs from food-tolerant individuals can also mount significant
lymphoproliferative responses when stimulated in vitro9. Studies that determined
cytokine production in food antigen-stimulated PBMCs, showed that food-allergic
patients have a Th2-skewed response compared with non-allergic controls10-14. In
these studies however, cytokines were measured in bulk cultures of T cells, making
it difficult to extrapolate these results to the individual T cell. Food-reactive Th2
cells have been cloned from blood of patients with food allergy15-17, but the food-
specific T cell response in food-tolerant subjects has not been evaluated at the
clonal level.
Cow's milk is among the first foods introduced into an infant's diet and thus one of
the most common causes of food allergy in young children18,19. Cow's milk allergy
(CMA) plays a pathogenetic role in approximately 35-40% of infants with AD20-22.
In these patients, ingestion of cow's milk leads to acute cutaneous symptoms and/or
aggravation of the eczema. The aim of this study was to analyze the CMP-specific
T cell response in infants with AD and CMA. We used an antigen-specific
culturing system to establish CMP-specific T cell clones (TCCs) from blood of
infants with AD under the age of 1 year. A comparison of T cell reactivity and
cytokine production was made between infants with CMA, and infants tolerant for
cow's milk.
METHODS
Patients & control subjects
Twelve infants (7 males, 5 females; age 3.8-12.3 months, median 6.4) with AD
according to the criteria of Hanifin & Rajka23 were included in the study. The study
was approved by the Medical Ethical Committee of the University Medical Center,
Utrecht. After informed consent was obtained, a venous blood sample was taken.
Cow's milk allergy was diagnosed by complete elimination of cow's milk from the
infant's diet, followed by a cow's milk challenge. Infants that developed symptoms
during challenge (Table 1) that disappeared during subsequent elimination were
diagnosed with CMA (CMA patients). Infants without CMA (non-CMA patients)
did not have any reactions, and no significant change in the severity of the eczema
was noted throughout the entire elimination-provocation period. Age of CMA
patients was not significantly different (p = 0.94) from non-CMA patients; 3.8 -
12.3 months (median 6.4) vs. 4.4 - 7.3 months (median 6.5).
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Cow's milk antigens
Purified cow's milk proteins (CMPs) (used at concentrations of 50 µg/ml): total
casein, α-lactalbumin and β-lactoglobulin, and purified casein-subfractions (used at
concentrations of 10 µg/ml ): αS1-casein, αS2-casein, β-casein and κ-casein were
kindly provided by Dr. E.C.H. van Beresteijn (Netherlands Institute for Dairy
Research, Ede, The Netherlands). A mix of purified CMPs containing equal
quantities of total casein, α-lactalbumin and β-lactoglobulin (each at a
concentration of 50 µg/ml) is referred to as CMP-mix.
Culture media
Proliferation assays with PBMCs were performed with complete medium AIM V
(Gibco, NY, USA). For culturing of T cell lines and TCCs, and in lymphocyte
stimulation tests (LSTs), complete medium RPMI-1640 (Gibco) was used,
supplemented with 10% pooled human AB serum. Epstein Barr virus (EBV)-
transformed B cells were cultured in RPMI-1640 (Gibco), supplemented with 10%
fetal calf serum (Gibco). Established TCCs were maintained in Iscove’s Modified
Dulbecco’s Medium (Gibco) supplemented with 2% pooled human AB serum and
Table 1. Characteristics of infants with AD, with and without CMA.
Patient Symptoms* IgE SPT
1 † Erythema, AD - -
2 ‡ - - -
3 † Erythema, UR, AD + +
4 † Erythema, AD - +
5 ‡ - - -
6 † Erythema, AD - +
7 ‡ - - -
8 † Erythema, UR + +
9 ‡ - - -
10 † Erythema, UR, AD + +
11 ‡ - - +
13 ‡ - - -
† CMA patient
‡ non-CMA patient
* symptoms developed upon challenge
AD = worsening of atopic dermatitis
UR = urticaria
IgE = cow's milk-specific IgE detected by RAST
SPT = skin prick test for cow's milk
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5% Yssel's medium24. All media were supplemented with penicillin (100 IU/ml),
streptomycin (100 mg/ml) and glutamin (1mM) (Gibco).
Proliferation assays with PBMCs
PBMCs were isolated from heparinized venous blood by using Ficoll density
gradient centrifugation. Recovered cells were cultured in quadruplicate (105
cells/well) at 370C under 5% CO2 for 6 days in 96-well U-bottom culture plates
(Greiner, Frickenhausen, Germany) in the presence or absence of antigen. After 6
days of culturing, proliferation was measured by using tritiated thymidine ([3H]-
TdR) incorporation; [3H]-TdR (1µCi/well; Amersham, Aylesbury, UK) was added,
and the cells were harvested after 18 hours. Thymidine incorporation was measured
using a 1205 betaplatetm counter (Wallac, Turku, Finland).
LST
LSTs were performed in triplicate in 96-well U-bottom plates (Greiner). Each well
contained 4x104 T cells, and 4x104 irradiated (50 Gy) autologous EBV-transformed
B cells as antigen-presenting cells. The EBV-transformed B cells were, before co-
culture with T cells, incubated O/N with antigen. EBV-transformed B cells
incubated without antigen were used as negative controls. After 24 hours of
culturing, proliferation was measured by using [3H]-TdR incorporation as
described above.
Preparation of CMP-specific TCCs
Cow's milk protein-specific TCCs were established from heparinized venous blood
as described previously25,26. In parallel to the proliferation assays, PBMCs were
cultured in a 24-well flat bottom culture plate in the presence of CMP-mix. After 7
days, 50 IU/ml of both rIL-2 and rIL-4 (kind gift of Novartis Research Institute,
Vienna, Austria) was added to the culture medium. To promote expansion of CMP-
specific T cells, cultures were re-stimulated every 14 days with irradiated
autologous EBV-transformed B cells that had been pre-incubated O/N with CMP-
mix, as antigen-presenting cells. LST or determination of cytokine release was
always done at the start of a re-stimulation cycle. After 2-3 weeks, when a
polyclonal T cell culture was obtained, CMP-specificity was verified by LST. If
these cultures indicated a high CMP-specific T cell proliferation, T cells were
cloned by limiting dilution at 0.3, 1 or 3 cells/well in 96-well U-bottom culture
plates in the presence of IL-2, IL-4 and irradiated autologous EBV-transformed B
cells (104/well) that had been pre-incubated O/N with CMP-mix. Established
clones were screened for CD4 or CD8 and TCR expression. Cells were stained
with fluorescein isothiocyanate (FITC)-conjugated anti-CD4 (Leu-3a, Becton-
Dickinson, San Jose, USA) and phycoerythrine-conjugated anti-CD8 (Leu-2a,
Becton-Dickinson), or FITC-conjugated anti-α/β TCR (WT-31, Becton-
Dickinson), fixed in paraformaldehyde, and analyzed with FACScan (Becton-
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Dickinson). All TCCs were tested in LST to verify CMP-specificity, and to
determine specificity for the different proteins in cow's milk.
CMP-specific cytokine release
To determine CMP-specific cytokine release, 106 cells of each TCC were incubated
with 106 irradiated autologous EBV-transformed B cells that had been pre-
incubated O/N with CMP-mix. Control cultures of TCCs and EBV-transformed B
cells, pre-incubated without antigen were prepared in parallel. Stimulation was
performed in a 24-well plate. After 24 hours of culture at 370C, supernatants were
collected and stored at -200C. Cytokines were measured by ELISA according to the
manufacturers recommendations; IL-4, IL-13, IFN-γ: Central Laboratory of the
Blood Transfusion Service, Amsterdam, The Netherlands, IL-5: Endogen, Woburn,
USA. The detection limit was 0.6 pg/ml for IL-4, 5 pg/ml for IL-5, 0.5 pg/ml for
IL-13 and 2 pg/ml for IFN-γ. CMP-specific cytokine release by a TCC was
calculated by subtracting control-stimulated cytokine production from cytokine
production after stimulation with CMP-mix.
Statistical analysis
Non-parametric analysis (Wilcoxon signed-rank test and Mann-Whitney U test)
was applied to determine significant differences between patient and control groups
with regard to age, proliferative responses of PBMCs, and cytokine production by
TCCs. Differences associated with p values of less than 0.05 were considered
significant. Nonparametric Spearman's rank correlation was used to test for
correlation between production of different cytokines.
RESULTS
CMP-specific proliferation in PBMCs
Antigen-specific proliferation of PBMCs was determined for the three major
allergens in cow's milk: total casein, α-lactalbumin and β-lactoglobulin.
Proliferative responses towards each of the three antigens were found in both CMA
patients and non-CMA patients (Figure 1). In CMA patients, responses towards all
three allergens were significantly higher than background responses (p<0.05). The
range of these responses however was quite large and overlapped extensively
between CMA and non-CMA patients. Mean T cell proliferation in CMA patients
tended to be higher than in non-CMA patients, but these differences were not
significant. Also, comparison of mean stimulation-index (ratio of counts per minute
of antigen-stimulated cultures to unstimulated cultures) showed no significant
differences in proliferative responses of PBMCs between CMA and non-CMA
patients for each of the major cow's milk allergens (data not presented).
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Figure 1. Proliferative responses of PBMCs from 12 infants with atopic dermatitis, 6 with
cow's milk allergy (CMA) and 6 without cow's milk allergy (non-CMA), to the three major
cow's milk allergens. Tritiated thymidine incorporation was measured 6 days after
stimulation with the allergens.
Table 2. T cell clone reactivity towards the major cow's milk proteins and protein-
subfractions in infants with AD, with and without CMA.
Casein proteins Whey proteins
Pt TCCreactivity no*
αS1 αS2 β κ § α-lac β-lac
1 † cas/whey 23 8 2 1 3 9
3 † cas/whey 17 2 1 4 3 5 2
4 † cas 3 3
8 † cas 7 2 3 1 1
2 ‡ cas 4 1 3
5 ‡ cas 3 1 1 1
7 ‡ cas/whey 7 2 5
11 ‡ cas/whey 29 1 28
† CMA patient
‡ non-CMA patient
* number of TCCs obtained from each patient
§ TCCs specific for total casein, specificity for the casein-subfractions could not be determined
α-lac = α-lactalbumin
β-lac = β-lactoglobulin
102
103
104
105
background casein α-lactalbumin β-lactoglobulin
non-CMA
median
25/75%
range
*p < 0.05
*p < 0.05
*p < 0.05
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non-CMA
CMA
CMA
CMA
non-CMA
non-CMA
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CMP-specific TCCs: reactivity towards the various protein fractions in cow's
milk
A total of 93 CMP-specific TCCs was obtained. Fifty TCCs were obtained from 4
CMA patients, 43 TCCs were obtained from 4 non-CMA patients. The cloning
procedure did not yield TCCs in the other 4 patients. Flow-cytometric analysis
showed that all clones were CD4+ and expressed the α/β TCR (data not presented).
Specificity of the clones was determined for the casein and whey-proteins, and for
the protein-subfractions (Table 2). TCC reactivity towards the casein and whey
proteins was observed in both allergic and non-CMA patients and was not
significantly different between the two groups.
Production of IL-4 and IFN-γ
Cow's milk protein-specific cytokine release was measured in 44 CMP-specific
TCCs derived from CMA patients and 43 TCCs derived from non-CMA patients.
Figure 2 shows production of IL-4 and IFN-γ. In CMA patients (Figure 2A),
antigen-specific TCCs with a diverse cytokine pattern were found; TCCs showed
isolated production of IL-4 or IFN-γ, or production of both cytokines. Clones from
non-CMA infants (Figure 2B) showed a different pattern; none of the clones
produced high levels of IL-4 (maximum 0.36 ng/ml), and 79% of these TCCs
produced even less than 0.1 ng/ml of IL-4. A significant portion of the clones
derived from non-CMA patients produced high amounts of IFN-γ, up to 30 ng/ml,
Figure 2. Antigen-specific production of IL-4 and IFN-γ by cow's milk-specific T cell clones
established from infants with atopic dermatitis, with cow's milk allergy (A) and without cow's
milk allergy (B). Cytokine production was measured in culture supernatants, 24 hr after
stimulation with irradiated autologous EBV-transformed B cells, pre-incubated O/N with
cow's milk proteins.
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the rest (mostly TCCs from patient 11/TW) produced very small amounts of both
IL-4 and IFN-γ. To phenotype the T cell clones according to their production of IL-
4 and IFN-γ, an arbitrary classification was used that was adapted from a previous
study with CMP-specific T cell clones27 (Table 3).
Comparison of the CMP-specific cytokine response in infants with, and
without CMA
To compare the overall Th1/Th2 skewing of the CMP-specific T cell response of
infants with clinical reactions to cow's milk and infants without CMA, for each
cytokine, mean production by all CMP-specific TCCs from each patient was
calculated (Table 4). In infants with CMA, mean IL-4 production was markedly
higher than in non-CMA infants, who showed a very low mean production of IL-4.
This difference was statistically significant (Mann Whitney-U; p<0.05). Mean
production of IL-5 and IL-13 was also markedly higher in CMA infants than in
non-CMA infants. In contrast, mean production of IFN-γ was markedly higher in
non-CMA infants, compared with the CMA infants. Although the differences in
production of IL-5, IL-13 and IFN-γ did not reach statistical significance, when all
clones from CMA patients (n=44) were pooled and compared with the mean
cytokine production of all clones from non-CMA patients (n=43), these differences
were all statistically significant (Mann Whitney-U; p<0.001) (data not presented).
Table 3. Phenotype of cow's milk-specific T cell clones from infants
with AD, with and without CMA.
Patient no of TCCs Th2* Th0* Th1*
1 † 20 2 (10%) 6 (30%) 12 (60%)
3 † 15 3 (20%) 9 (60%) 3 (20%)
4 † 3 2 (67%) 1 (33%) 0
8 † 6 4 (66%) 1 (17%) 1 (17%)
2 ‡ 4 0 0 4 (100%)
5 ‡ 3 0 0 3 (100%)
7 ‡ 7 0 1 (14%) 6 (86%)
11 ‡ 29 0 29 (100%) 0
† CMA patient
‡ non-CMA patient
* Th2 phenotype was defined by: IL-4 > 0.4 ng/ml and IFN-γ < 1 ng/ml
Th0 phenotype was defined by: IL-4 < 0.4 ng/ml and IFN-γ < 1 ng/ml,
or IL-4 > 0.4 ng/ml and IFN-γ > 1 ng/ml
Th1 phenotype was defined by: IFN-γ > 1 ng/ml and IL-4 < 0.4 ng/ml
Chapter 2
32
Correlation between IL-4 release, and release of IL-5 and IL-13
To determine the association between CMP-specific production of IL-4 and release
of other Th2-type cytokines during stimulation with cow's milk, correlation
analysis was performed (Figure 3). Both production of IL-5 (Figure 3A) and IL-13
(Figure 3B) was significantly correlated with IL-4 production.
DISCUSSION
In this study, we analyzed the CMP-specific T cell response in infants with AD and
allergy for cow's milk, and in infants with AD tolerant for cow's milk. The results
from the proliferation assays confirmed that lymphoproliferative responses to the
major allergens in cow's milk exist in PBMCs of infants with AD8,9,28.
To analyze the CMP-specific T cell response at the clonal level, CMP-specific T
cell clones were established. We show that infants with AD have a CMP-specific T
helper cell response, irrespective of their (cow's milk-) allergic state. This response
may be directed against all the major proteins in cow's milk and is not restricted to
a particular subfraction.
Determination of cytokine release showed a clear dichotomy between the
Table 4. Mean cytokine production by cow's milk-specific T cell clones from infants with AD,
with and without CMA.
Patient No* IL-4 (ng/ml) IL-5 (ng/ml) IL-13 (ng/ml) IFN-γ (ng/ml)
1 † 20 0.76 ± 0.29 7.96 ± 1.23 7.85 ± 0.87 2.71± 0.64
3 † 15 1.86 ± 0.60 4.37 ± 1.20 3.97 ± 1.03 2.39 ± 0.53
4 † 3 14.53 ± 1.46 50.62 ± 18.78 14.28 ± 2.42 1.92 ± 1.67
8 † 6 3.08 ± 1.41 16.83 ± 7.13 11.09 ± 3.90 0.70 ± 0.15
2 ‡ 4 0.1 ± 0.1 6.15 ± 6.07 5.23 ± 4.11 14.50 ± 5.09
5 ‡ 3 0.04 ± 0.02 1.14 ± 0.90 1.11 ± 0.84 3.34 ± 1.18
7 ‡ 7 0.2 ± 0.04 9.26 ± 4.33 6.12 ± 2.21 7.85 ± 4.04
11 ‡ 29 0.02 ± 0.01 0.29 ± 0.06 0.19 ± 0.05 0.01 ± 0.01
CMA patients n=4 5.06 ± 3.19* 19.94 ± 10.55 9.30 ± 2.21 1.93 ± 0.44
Non-CMA patients n=4 0.09 ± 0.04* 4.21 ± 2.12 3.16 ± 1.47 6.43 ± 3.14
results are expressed as mean ± SEM
* number of TCCs obtained from each patient
† CMA patient
‡ non-CMA patient
§ differences between CMA and non-CMA patients are significantly different (p<0.05)
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production of IL-4 in infants with, and without CMA. In TCC from infants with
CMA, production of IL-4 was generally high, while none of the 43 clones derived
from milk tolerant infants produced significant amounts of IL-4 (Figure 2).
The obtained TCCs were phenotyped according to their production of IL-4 and
IFN-γ, based on criteria that were previously used to designate Th2, Th0 and Th1
subsets in CMP-specific TCCs27. According to this arbitrary classification, the
CMP-specific T cells from infants with CMA were predominantly from the Th2-
type and Th0-type, while the non-CMA infants did not have any CMP-specific Th2
cells, but had predominantly CMP-specific T cells from the Th1-type (Table 3).
Studies that evaluate human T cell clones generally designate distinct TCC-
phenotypes similar to the Th1 and Th2 subsets that were originally found in murine
models29,30. It has become clear however, that human T cells producing a clear-cut
Th1 or Th2 cytokine profile as can be observed in mice, form two ends of a
continuous spectrum in which most T cells produce a more heterogeneous cytokine
profile31-33. Criteria for human Th2-Th0-Th1 subsets vary considerably between
reports and each classification remains arbitrary31,34. For this reason, we analyzed
differences between cytokine profiles of antigen-specific T cells from cow's milk-
allergic and cow's milk-tolerant infants also by comparison of the absolute amounts
of each individual cytokine (Table 4). This showed that in the infants with allergic
reactions to milk, mean production of IL-4 was much higher than in the non-
allergic infants. In contrast, mean production of IFN-γ was higher in the infants that
B
1001010.10.010.001
0.1
100
10
1
0.01
0.001
IL
-1
3
(n
g/
m
l)
r=0.753
n=87
p<0.001
IL-4 (ng/ml)
0.1
100
10
1
0.01
0.001
IL
-5
(n
g/
m
l)
1001010.10.010.001
A
r=0.783
n=87
p<0.001
IL-4 (ng/ml)
Figure 3. Correlation between antigen-specific production of IL-4 and IL-5 (A), and IL-4 and
IL-13 (B) by cow's milk-specific T cell clones established from infants with atopic dermatitis,
with and without cow's milk allergy. Closed circles represent clones from allergic infants,
open circles represent clones from non-allergic infants. Cytokine production was measured
in culture supernatants, 24 hr after stimulation with irradiated autologous EBV-transformed B
cells, pre-incubated O/N with cow's milk proteins.
IL
-1
3 
(n
g/
m
l)
IL
-5
 (n
g/
m
l)
Chapter 2
34
were tolerant for cow's milk. Three of these patients had a high IFN-γ production,
while one patient had a cytokine response dominated by very low production of
both IL-4 and IFN-γ.
In addition to IL-4, we determined the CMP-specific production of IL-5 and IL-13,
two cytokines that are closely associated with the Th2 response, and which are
potent inducers of allergic inflammation through recruitment of eosinophils and the
induction of IgE synthesis35,36. In the CMA infants, production of IL-5 and IL-13
was high, while it was markedly lower in patients without CMA. Correlation
analysis showed that release of both IL-5 and IL-13 was strongly correlated with
IL-4 production, indicating that in CMP-specific T cells, release of Th2-cytokines
is closely related.
Taken together, these results show that CMA in infants with AD is associated with
a Th2-skewed CMP-specific T helper cell response in blood, while tolerance to
cow's milk is associated with much lower levels of these cytokines and a Th1-
skewed cytokine response.
The elaborate process of establishing antigen-specific T cell clones hampers the
evaluation of large groups of patients. Due to the small sample size of 4 patients in
each group, only a trend could be observed and statistical significance was not
reached for all differences. However, when the TCCs from all allergic patients
were pooled and mean cytokine production was compared with all clones from
non-CMA patients, differences that were observed "at the patient level" between
both groups were all statistically significant. This strongly suggests that these
findings represent real differences that exist between cow's milk-allergic and cow's
milk-tolerant infants with AD.
So far, only three previous studies have analyzed isolated T cell clones specific for
CMPs27,37,38. In these studies, only the casein fraction of cow's milk was used for T
cell culturing and, as a consequence, only casein-specific T cell clones were
generated. Reekers and co-workers described 14 casein-specific T cell clones,
established from 3 children with AD and allergic reactions to hen’s egg and cow's
milk38. These TCCs had been obtained using mitogenic, polyclonal stimulation, a
method which may dramatically affect the primary responding T cell population14,
and may have resulted in only 43% of the obtained TCCs belonging to the CD4+
subset. Cytokine release by TCCs is also often determined after exposure to
mitogenic stimuli, such as anti-CD3/anti-CD28 antibodies17 or concavalin A27,38.
However, in vitro cytokine release by TCCs activated through these non-specific
stimuli can be markedly different from cytokine production following antigen-
specific stimulation15,17. For these reasons, we propagated and activated the CMP-
specific TCCs in our study using an antigen-specific culture system with
autologous B cells as antigen-presenters, and did not use non-specific mitogens.
We believe that in this antigen-specific in vitro system, the observed reactivity of T
cells is a good representation of the in vivo reactivity.
In summary, reports that evaluate the T cell response against food antigens at the
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clonal level are scarce15-17,27,38. The present study is the first to analyze food-
specific T cell clones from food-tolerant individuals and to directly compare T cell
reactivity and cytokine profiles from allergic and (age-matched) food-tolerant
subjects. The results show that, while food allergy is associated with high
production of Th2-cytokines, the food-specific T helper response in food-tolerant
individuals is characterized by low levels of these cytokines. Especially the minute
production of IL-4 in these infants, the hallmark cytokine of the allergic 'Th2'
response, suggests a key role for the T helper-cell derived Th2 cytokines in food
allergy-related skin symptoms. More studies on the mechanisms that determine
Th1/Th2 skewing of the food antigen-specific T cell response39 and the precise
mechanisms through which circulating food-reactive Th2 cells mediate allergic
inflammation in the skin40 are needed to give future directions for the development
of therapy in food allergy and AD.
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Chapter 3
Cow’s milk-specific T cells in blood of non-allergic
infants without atopy display a Th0-phenotype
RP Schade, AG Van Ieperen-Van Dijk, JLL Kimpen, CAFM Bruijnzeel-Koomen,
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ABSTRACT
Cow’s milk protein (CMP)-specific T cells are present in blood of infants with
atopic dermatitis, irrespective of their CMP-allergic state. However, only T cells
from patients with allergy to CMPs show a high production of Th2 cytokines. It is
presently unclear if these results can be extrapolated to individuals without atopy.
In this study, three non-atopic infants (mean age 8.0 months) were investigated,
who did not have allergy to cow’s milk or other foods, and in whom atopy was
excluded by clinical and in vitro investigations. Using an antigen-specific culturing
system, CD4+ CMP-specific T cell clones (TCCs) (n=75) specific for the major
CMPs were established from blood. These TCCs showed a Th0-like phenotype,
with a closely correlated production of IL-4 and IFN-γ. Release of IL-4 was lower
compared to CMP-specific T cells from atopic patients with cow’s milk allergy.
These findings demonstrate for the first time at the clonal level, that a T helper cell
response directed against the major proteins in milk is present in CMP-tolerant
individuals without atopy. The ‘Th0-like’ cytokine release, and the low Th2
cytokine production, suggests that tolerance to milk in normal individuals is not
caused by absence of circulating, CMP-specific T cells, but is probably determined
by the cytokine profile of these cells.
INTRODUCTION 
Food antigens are the most important allergens that cause allergic reactions during
infancy and childhood. Antigen-specific T cells have been connected with the
aetiology of food allergy and food-allergic reactions1. In a previous study we
showed, at the clonal level, that cow’s milk protein (CMP)-specific T cells are
present in blood of infants with atopic dermatitis (AD), irrespective of their cow’s
milk-allergic state2. The CMP-specific T cells from patients that have allergic
reactions to cow’s milk however, show a significantly higher production of Th2
cytokines compared with patients that do not have cow’s milk allergy (CMA)2.
This finding suggests an important role for the Th2 cytokines in food allergy-
related skin symptoms, similar to the role of Th2 cells in AD and inhalation
allergy3.
It is clear however, that atopic diseases are characterized by aberrant T cell
responses4,5. Although studies have shown food-specific proliferation in PBMCs of
normal, non-atopic controls6-8, the presence of food-specific T cells has not yet
been confirmed in non-allergic, non-atopic individuals at the clonal level so far.
The previous observations on T cell cytokine release in atopic individuals can
therefore not be extrapolated to normal individuals without an atopic
predisposition.
The aim of the current study was to investigate the presence of T cells, specific for
T cells in blood of non-atopic infants
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CMPs, in blood of non-allergic individuals without atopic disease. An antigen-
specific T cell culturing system with autologous B cells as antigen-presenting cells
was used to establish CMP-specific T cell clones (TCCs) from blood of three non-
atopic infants without allergy to cow’s milk. Specificity of the TCCs for the
various protein-fractions in milk, and cytokine release was investigated.
METHODS  
We studied 3 non-atopic infants, age 6.4 - 9.9 months (mean 8.0), who were not
allergic to cow’s milk or other foods. Atopy was excluded by negative family
history, absence of clinical atopic disorders (eczema, asthma or rhinitis), and by in
vitro diagnostics: infants did not have increased total IgE levels, and were not
sensitized for a panel of 12 common inhalation and food allergens as determined
by CAP system FEIA (Pharmacia Diagnostics, Uppsala, Sweden). No systemic or
topical immunomodulatory drugs were used. Blood samples were taken after
informed consent was obtained.
CMP-specific TCCs were established from blood as described previously2. In
short, PBMCs were isolated from heparinized venous blood, and subsequently
cultured using an antigen-specific culturing system with irradiated autologous
EBV-transformed B cells, pre-incubated O/N with CMPs, as antigen-presenting
cells. Culturing was performed in the presence of IL-2 and IL-4 (kind gift of
Novartis Research Institute, Vienna, Austria). If these cultures indicated a high
CMP-specific T cell proliferation in the lymphocyte stimulation test (LST), T cells
were cloned by limiting dilution. Established TCCs were tested in LST to
determine specificity for the various different CMPs.
CMP-specific release of IL-4 and IFN-γ by the TCCs was determined as described
previously2. In short, 106 cells of each TCC were incubated with 106 irradiated
autologous EBV-transformed B cells, pre-incubated O/N with CMPs. Cytokine
production was measured in cell-free supernatants obtained after 24 hours of
culture, by ELISA. Student’s t-test was used to determine differences between
cytokine production. Spearman's rank correlation was used for correlation analysis.
A p-value < 0.05 was considered significant. 
RESULTS
CMP-specific T cells: reactivity towards the various protein fractions in cow's
milk
A total of 75 CMP-specific TCCs was obtained. Flow-cytometric analysis showed
that all TCCs were CD4+ and expressed the α/β TCR (data not presented). For all
TCCs, specificity towards the major CMPs, casein and whey, and their subfractions
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was determined. Sixty-six TCCs (88%) were specific for casein, 9 TCCs (12%) for
whey. Specificities for casein subfractions were: αS1-casein (26 TCCs), αS2-
casein (8 TCCs), β-casein (21 TCCs), κ-casein (8 TCCs), not determined (3
TCCs). Specificities for the whey subproteins: α-lactalbumin (4 TCCs), β-
lactoglobulin (5 TCCs).
CMP-specific T cells display a Th0-phenotype
Figure 1 shows CMP-specific production of IL-4 and IFN-γ by individual TCCs.
Most clones showed a Th0-like phenotype, with comparable production of IL-4
and IFN-γ. Correlation analysis showed that production of IL-4 and IFN-γ was
significantly correlated in all TCCs: rs = 0.715, p<0.001). Mean cytokine
production for each patient is shown in Table 1.
Comparison of cytokine production with CMP-specific T cells from atopic
infants
Cytokine production by the CMP-specific TCCs was compared with CMP-specific
TCCs from age-matched atopic infants that have been described previously2. TCCs
from infants with atopy and CMA show a Th2-like cytokine pattern, while atopic
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Figure 1. CMP-specific production of IL-4 and IFN-γ by CMP-specific TCCs derived from
non-atopic infants without CMA. Most TCCs show a Th0-like phenotype, with comparable
production of IL-4 and IFN-γ. Production of both cytokines is significantly correlated.
(p<0.001). Cytokine production was measured in culture supernatants 24 hours after
stimulation with irradiated, autologous, EBV-transformed B cells preincubated overnight with
CMPs.
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infants that do not have CMA display a Th1-skewed pattern2 (Table 2). Mean
cytokine production by the CMP-specific TCCs from the non-allergic, non-atopic
infants shows a Th0-like cytokine profile, with a lower production of IL-4 than
infants with CMA, and a lower production of IFN-γ than atopic infants without
CMA (Table 2). No significant correlation was found between production of IL-4
and IFN-γ in TCCs from atopic infants (data not presented).
DISCUSSION
The findings in this report demonstrate for the first time at the clonal level, that a
CMP-specific T helper cell response exists in non-atopic infants without CMA.
This response is directed against all the major proteins in cow's milk and is not
restricted to a particular subfraction.
The finding that, besides atopic individuals, also individuals without an atopic
Table 1. Mean cytokine production by cow's milk-specific
TCCs from individual non-atopic infants without CMA.
Patient IL-4 (ng/ml) IFN-γ (ng/ml)
I 0.05 ± 0.02 0.05 ± 0.02
II 1.94 ± 0.56 2.19 ± 1.40
III 1.59 ± 0.22 1.62 ± 0.30
results are expressed as mean ± SEM
Table 2. Comparison of cytokine production by TCCs from
non-atopic infants with atopic infants, with and without CMA,
who have been described previously2.
Patient group IL-4 (ng/ml) IFN-γ (ng/ml)
Non-atopic controls* 1.19 ± 0.58 1.29 ± 0.64
CMA patients† 5.06 ± 3.19 1.93 ± 0.44
Atopic controls*† 0.09 ± 0.04 6.43 ± 3.14
results are expressed as mean ± SEM of results from pooled clones
from each individual patient
* infants without CMA
† infants with atopy
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predisposition have a CMP-specific T cells in blood, proves that clinical tolerance
to milk in normal individuals is not caused by absence of CMP-specific T cell
responses.
Analysis of cytokine release showed that the CMP-specific T cells display a
balanced, relatively low production of IL-4 and IFN-γ, i.e. a Th0-like phenotype.
This was clearly demonstrated by the significant correlation between IL-4 and IFN-
γ in all (n=75) TCCs derived from these infants, which was absent in TCCs derived
from atopic infants. Comparison of cytokine production with CMP-specific T cells
from age-matched CMA patients showed that release of IL-4 by CMP-specific T
cells from non-allergic, non-atopic infants is lower than in patients with allergy.
Similar results were found for the production of IL-5 and IL-13 (data not
presented). These findings add to the hypothesis that high release of Th2-cytokines
by circulating antigen-specific T cells plays an important role in the aetiology of
allergic reactions, whereas low release is associated with tolerance3-5.
Allergen-specific T cell responses to foods are already present at birth in virtually
all individuals, and are Th2-biased during the perinatal period4,9. From studies in
PBMCs, it was suggested that T cell responses in individuals without an atopic
predisposition postnatally deviate to a Th1-biased pattern, to prevent sensitization
to environmental allergens4,9. The results described here, however, show that when
investigated at the single cell level, the T cell response to milk in non-atopic
individuals displays a balanced, Th0-like cytokine profile, with a comparable
production of IL-4 and IFN-γ. This suggests that the fetal Th2-biased response to
milk is indeed downregulated, but becomes a balanced Th0-response, instead of a
Th1-biased response. It is clear that the strong inflammatory capacities of Th1-
cytokines such as IFN-γ can be harmful. Therefore, as cow’s milk is encountered in
large quantities during infancy, its seems more logically that a balanced (i.e. Th0-
like) cytokine reponse to milk is better than a Th1-response that is dominated by
IFN-γ production.
In conclusion, these results demonstrate that non-atopic individuals have CD4+,
CMP-specific T cells with a balanced, Th0-phenotype present in blood. This
indicates that tolerance to milk in normal individuals is not caused by absence of
circulating, CMP-specific T cells, but is probably determined by the low release of
Th2-cytokines by these cells.
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Spontaneous tolerance in cow's milk allergic infants
is associated with a deviation towards a Th1-cytokine
profile
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ABSTRACT
Background Food-specific T cell reactivity plays an important role in the
aetiology of food allergy. Cow’s milk allergy (CMA) is the major food allergy in
infancy and is associated with the spontaneous development of tolerance within
two years. This process is thought to be mediated by antigen-specific T cells, but
has not yet been studied at the T cell level.
Objective This study was designed to analyze changes in the cow's milk
protein (CMP)-specific T cell response during the spontaneous development of
tolerance for cow's milk in infants with atopic dermatitis (AD) and CMA.
Methods We used an antigen-specific culturing system with autologous B
cells as antigen-presenting cells to establish 65 CMP-specific T cell clones (TCCs)
from blood of 4 infants with AD and CMA. CMP-specific TCC-reactivity,
measured by lymphocyte stimulation test, and cytokine production, measured by
ELISA, was compared before and after the spontaneous development of tolerance
for each patient. To control for age-related changes we also studied 85 CMP-
specific TCC from 4 age-matched infants with AD but without CMA.
Results  CMP-specific production of the Th2 cytokines (IL-4, IL-5, and IL-
13), which was abundant at the allergic state, was lower after the development of
tolerance. In contrast, production of IFN-γ (Th1-cytokine) was increased. Age-
matched control patients without CMA showed a Th1-skewed CMP-response
during infancy, which changed to a Th0-like cytokine response after infancy.
Conclusions The spontaneous development of tolerance in cow's milk allergic
infants is associated with a deviation from a Th2-biased to a Th1-biased CMP-
specific T cell response. These results indicate that CMP-specific T cells play an
important role in the development of allergy and tolerance to cow's milk in infants
with CMA and AD.
INTRODUCTION
Food antigens are the main allergens that cause allergic reactions during infancy
and childhood1,2. Antigen-specific T cells have been connected with the aetiology
of food allergy and food allergic reactions. Food-specific T cell reactivity and
cytokine production has been demonstrated in food-stimulated PBMCs3-7 but as
these results were observed in bulk cultures of T cells, they are difficult to
extrapolate to the individual T cell. In a previous study, we have investigated
differences in antigen-specific T cell reactivity between infants with and without
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food allergy at the clonal level8. We found that food allergy in patients with atopic
dermatitis (AD) is associated with high production of the Th2 cytokines by
(circulating) food allergen-specific T cells. This suggests a key role for these cells
in food allergy-related skin symptoms, similar to the role of Th2 cells in AD and
inhalation allergy9,10.
The most important food antigen in young children is cow’s milk11,12. It is the
aetiological factor of acute cutaneous symptoms and/or aggravation of the eczema
in approximately 35-40% of infants with AD13,14. Cow's milk allergy (CMA) in
infancy is associated with the spontaneous development of tolerance within 2-3
years. This feature results in more than 85% of the infants with CMA tolerating
cow's milk without problems at the age of three years2,15. The immunological
mechanisms that mediate this process are mostly unknown, and have only been
investigated at the humoral level16-18. However, because of their key role in the
aetiology of allergy to cow’s milk, it is of importance to investigate the role of
antigen-specific T cells in the development of tolerance to cow’s milk.
In this study, we investigated changes in the cow’s milk protein (CMP)-specific T
cell response during the spontaneous development of tolerance for cow's milk in
infants with CMA and AD. We used an antigen-specific T cell-culturing system
with autologous B cells as antigen-presenting cells to establish CMP-specific T cell
clones (TCCs) from blood of these infants, and from age-matched control infants
with AD, but without CMA. We compared CMP-specific T cell reactivity before
and after the spontaneous development of tolerance for cow's milk.
METHODS
Patients & control subjects
The study was approved by the Medical Ethical Committee of the University
Medical Center, Utrecht. Four infants with AD and CMA were included in the
study. Four infants with AD but without CMA were included as controls. Atopic
dermatitis was diagnosed according to the criteria of Hanifin and Rajka19. CMA
was diagnosed or excluded by complete elimination of cow's milk from the infant's
diet, followed by a cow's milk challenge procedure20. All infants with CMA
developed acute cutaneous symptoms. Table 1 shows characteristics of patients and
controls. Age of CMA patients was not significantly different (p = 0.79) from non-
CMA controls; 4.5 - 12.3 months (mean 7.0) vs. 6.1 - 7.4 months (mean 7.5). After
informed consent was obtained, venous blood was taken from patients and
controls.
One year after inclusion in the study, the allergic infants were re-evaluated for
CMA via cow's milk challenge. At this timepoint, all CMA patients had become
tolerant for CMPs and all the control patients still tolerated cow's milk without
problems (Table 1). Venous blood samples were taken from patients and controls.
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Cow's milk antigens
Purified CMPs (used at concentrations of 50 µg/ml): total casein, α-lactalbumin
and β-lactoglobulin, and purified casein-subfractions (used at concentrations of 10
µg/ml ): αS1-casein, αS2-casein, β-casein and κ-casein, were kindly provided by
Dr. E.C.H. van Beresteijn (Netherlands Institute for Dairy Research, Ede, The
Netherlands). A mix of purified CMPs containing equal quantities of total casein,
α-lactalbumin and β-lactoglobulin (each at a concentration of 50 µg/ml) is referred
to as CMP-mix.
Culture media
For culturing of T cell lines and TCCs, and in lymphocyte stimulation tests (LSTs),
complete medium RPMI-1640 (Gibco, New York, USA) was used, supplemented
with 10% pooled human AB serum. Epstein Barr virus (EBV)-transformed B cells
were cultured in RPMI-1640 (Gibco), supplemented with 10% fetal calf serum
(Gibco). Established TCCs were maintained in Iscove’s Modified Dulbecco’s
Medium (Gibco) supplemented with 2% pooled human AB serum and 5% Yssel's
medium 21. All media were supplemented with penicillin (100 IU/ml), streptomycin
(100 mg/ml) and glutamin (1 mM) (Gibco).
Table 1. Characteristics of infants with AD, with and without CMA.
1st timepoint 2nd timepoint
Patient Symptoms*
IgE SPT IgE SPT
Patient I Erythema, AD - - - -
Patient II Erythema, UR + + - -
Patient III Erythema, UR, AD + + + +
Patient IV Erythema, AD - + - +
Control I - - - - -
Control II - - - - nd
Control III - - - - -
Control IV - - - - -
* symptoms developed upon challenge during allergic state
AD = worsening of atopic dermatitis
UR = urticaria
IgE = cow's milk-specific IgE detected by Cap Pharmacia
SPT = positive skin prick test for cow's milk
nd = not done
Spontaneous tolerance and cytokine release
51
LST
LSTs were performed in triplicate in 96-well U-bottom plates (Greiner,
Frickenhausen, Germany). Each well contained 4x104 T cells, and 4x104 irradiated
(50 Gy) autologous EBV-transformed B cells as antigen-presenting cells. The
EBV-transformed B cells were, before co-culture with T cells, incubated O/N with
antigen. EBV-transformed B cells incubated without antigen were used as negative
controls. After 24 hours of culturing, proliferation was measured by using tritiated
thymidine ([3H]-TdR) incorporation; [3H]-TdR (1µCi/well; Amersham, Aylesbury,
UK) was added, and the cells were harvested after 18 hours. Thymidine
incorporation was measured using a 1205 betaplatetm counter (Wallac, Turku,
Finland).
Preparation of CMP-specific TCCs
CMP-specific TCCs were established as described previously8,22. PBMCs were
isolated from heparinized venous blood by using Ficoll density gradient
centrifugation. Recovered cells were cultured in a 24-well flat bottom culture plate
in the presence of CMP-mix. After 7 days, 50 IU/ml of both recombinant IL-2 and
IL-4 (kind gift of Novartis Research Institute, Vienna, Austria) was added to the
culture medium. To promote expansion of CMP-specific T cells, cultures were re-
stimulated every 14 days with irradiated autologous EBV-transformed B cells that
had been pre-incubated O/N with CMP-mix, as antigen-presenting cells. LST or
determination of cytokine release was always done at the start of a re-stimulation
cycle. After 2-3 weeks, when a polyclonal T cell culture was obtained, CMP-
specificity was verified by LST. If these cultures indicated a high CMP-specific T
cell proliferation, T cells were cloned by limiting dilution at 0.3, 1 or 3 cells/well in
96-well U-bottom culture plates in the presence of IL-2, IL-4 and irradiated
autologous EBV-transformed B cells (104/well) that had been pre-incubated O/N
with CMP-mix. Established TCCs were screened for CD4 or CD8 and T cell
receptor (TCR) expression. Cells were stained with fluorescein isothiocyanate
(FITC)-conjugated anti-CD4 (clone Leu-3a, BD Biosciences, San Jose, USA) and
phycoerythrine-conjugated anti-CD8 (clone Leu-2a, BD Biosciences), or FITC-
conjugated anti-α/β TCR (clone WT-31, BD Biosciences), fixed in
paraformaldehyde, and analyzed with FACScan (BD Biosciences). All TCCs were
tested in LST to verify CMP-specificity, and to determine specificity for the
different proteins in cow's milk.
CMP-specific cytokine release
To determine CMP-specific cytokine release, 106 cells of each TCC were incubated
with 106 irradiated autologous EBV-transformed B cells that had been pre-
incubated O/N with CMP-mix. Control cultures of TCCs and EBV-transformed B
cells, pre-incubated without antigen were prepared in parallel. Stimulation was
performed in a 24-well plate, final volume 1 ml. After 24 hours of culture at 370C,
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supernatants were collected and stored at -200C. Cytokines were measured by
ELISA according to the manufacturers recommendations; IL-4, IL-10, IL-13, IFN-
γ: Central Laboratory of the Blood Transfusion Service, Amsterdam, The
Netherlands, IL-5: Endogen, Woburn, USA. The detection limit was 0.6 pg/ml for
IL-4, 5 pg/ml for IL-5, 1.2 pg/ml for IL-10, 0.5 pg/ml for IL-13 and 2 pg/ml for
IFN-γ. CMP-specific cytokine release by a TCC was calculated by subtracting
control-stimulated cytokine production from cytokine production after stimulation
with CMP-mix.
Statistical analysis
Parametric analysis (Student’s t-test) was applied to determine significant
differences between patient and control groups with regard to age, and differences
in cytokine production between the two timepoints for each patient and control.
Parametric analysis (Pearson’s correlation) was used to test for correlation between
production of different cytokines. Differences associated with p values of less than
0.05 were considered significant.
RESULTS
CMP-specific TCC: reactivity towards the various protein fractions in cow's
milk
Forty-four TCCs were obtained from the 4 allergic patients at the first timepoint,
43 from the 4 age-matched control patients without CMA. At the second timepoint,
21 TCCs were isolated from 3 tolerant patients and 42 from 3 control patients. The
cloning procedure did not yield TCCs in 1 tolerant patient and in 1 control patient
at the second timepoint.
Flow-cytometric analysis showed that all clones were CD4+ and expressed the α/β
TCR (data not shown). Specificity of the TCCs was determined for the casein and
whey-proteins, and for the protein-subfractions (Table 2). TCC reactivity towards
the casein and whey proteins was observed at the first timepoint in both allergic
and controls and was not different between the two groups (Table 2A). At the
second timepoint, few whey-specific TCCs were obtained; they were derived from
the non-allergic controls (Table 2B). No major differences in casein-specific TCC
reactivity were observed between patients and controls at the second timepoint.
Production of Th2 cytokines vs Th1 cytokines
For each individual patient with CMA, we studied changes in CMP-specific
production of the hallmark Th2 cytokine (IL-4), and the hallmark Th1 cytokine
(IFN-γ) during the development of tolerance. Figure 1A shows results of the three
patients in which TCCs were obtained from both timepoints. In two patients with
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CMA, the development of tolerance was accompanied by a marked reduction in
Table 2A. First Timepoint: TCC reactivity towards the major CMPs in infants with AD and
CMA, and age-matched controls.
Casein proteins Whey proteins
Patient no*
αS1 αS2 β κ § α-lac β-lac
Patient I 20 6 2 1 3 8
Patient II 6 2 3 1
Patient III 15 2 1 3 3 4 2
Patient IV 3 3
Control I 4 1 3
Control II 3 1 1 1
Control III 7 2 5
Control IV 29 1 28
* number of TCCs obtained from each patient
§ TCC specific for total casein, specificity for the casein-subfractions could not be determined
α-lac = α-lactalbumin
β-lac = β-lactoglobulin
Table 2B. Second Timepoint: TCC reactivity towards the major CMPs and protein-
subfractions in infants tolerant for CMPs, and age-matched controls.
Casein proteins Whey proteins
Patient no*
αS1 αS2 β κ § α-lac β-lac
Patient I 7 1 5 1
Patient II 2 2
Patient III 12 4 6 2
Control I 11 10 1
Control II 18 14 1 2 1
Control III 13 6 3 3 1
* number of TCCs obtained from each patient
§ TCC specific for total casein, specificity for the casein-subfractions could not be determined
α-lac = α-lactalbumin
β-lac = β-lactoglobulin
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production of IL-4, and an increase in IFN-γ production. In the third patient, no
change in IL-4 production was seen. Production of IFN-γ at the tolerant state was
reduced to a very low level in this patient.
To control these results for age-related changes, we also investigated changes in
the CMP-specific cytokine production between the two timepoints in each
individual control patient. Figure 1B shows results of the three controls in which
TCCs were obtained from both timepoints. In contrast to the patient group, IL-4
production in the controls showed a marked increase between the two timepoints,
while IFN-γ production, which was high at the first timepoint, showed a decrease.
Results were tested for statistical significance using Student’s t-test. In 1 patient
and 1 control, statistical analyses were hampered by the fact that, at one of the
timepoints, a low number (≤3) of clones was established. Despite clear differences
(change in mean result of more than 75%) these results were only borderline
significant due to the low number of clones.
Figure 1. Mean production of IL-4 and IFN-γ by CMP-specific TCCs obtained from three
infants with CMA and AD (Figure 1A) during the allergic state (closed bars) and after the
development of tolerance for cow's milk (open bars), and from three age-matched controls
with AD without CMA (Figure 1B) at both timepoints. Asterisk represents: p<0.05 (Student’s
t-test).
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Production of IL-5 and IL-13, and correlation with IL-4 release
In addition to IL-4, we also measured CMP-specific production of IL-5 and IL-13,
two cytokines closely associated with the Th2 response. Table 3 shows results of
mean production at both timepoints. Similar to IL-4, the development of tolerance
in patients with CMA was accompanied by a marked reduction in production of IL-
5 and IL-13 in 2 of these patients. The third CMA patient showed mainly a
decrease in IL-13 at the development of tolerance. In contrast to the patient group,
production of IL-5 and IL-13 was unchanged between the two timepoints in the
control patients.
To study the association between the antigen-specific production of the Th2-
cytokines during stimulation with cow's milk, correlations between production of
IL-4, IL-5 and IL-13 were calculated. This showed that in all (n=87) TCCs
established at the first timepoint, and in all (n=63) TCCs from the second
timepoint, antigen-specific production of IL-4 and IL-5, production of  IL-4 and
IL-13,  and production of IL-5 and IL-13 were significantly correlated (p<0.001,
data not shown). There was no correlation between production of IFN-γ and any of
the Th2-cytokines.
Comparison of CMP-specific cytokine response in patients and controls, for
both timepoints
To compare the overall Th1/Th2 skewing of the CMP-specific T cell response of
infants with clinical reactions to cow's milk and infants without CMA, mean TCC
cytokine production in each patient group was calculated. Table 4 shows results
based on the three patients in which TCCs were obtained from both timepoints.
Cow's milk allergic infants have a Th2-skewed cytokine pattern with higher levels
Table 3. Production of IL-5 and IL-13 by TCCs from infants with AD, with and without CMA,
at two timepoints
IL-5 (ng/ml) IL-13 (ng/ml)Patient
1st timepoint 2nd timepoint 1st timepoint 2nd timepoint
Patient I 7.9 ± 1.2 0.5 ± 0.3 7.8 ± 0.8 3.4 ± 0.8
Patient II 16.8 ± 7.1 0.1 ± 0.0 11.0 ± 3.8 1.0 ± 1.0
Patient III 4.3 ± 1.2 4.4 ± 1.2 3.9 ± 1.0 1.0 ± 0.2
Patient IV 50.6 ± 18.7 * 11.1 ± 3.9 *
Control I 6.1 ± 6.0 3.0 ± 1.0 5.2 ± 4.1 3.5 ± 0.6
Control II 1.1 ± 0.9 2.2 ± 0.8 1.1 ± 0.8 0.9 ± 0.2
Control III 9.2 ± 4.3 7.6 ± 1.8 6.1 ± 2.2 2.6 ± 0.8
Control IV 0.2 ± 0.0 * 0.2 ± 0.0 *
* no TCCs obtained at this timepoint
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of IL-4, IL-5 and IL-13 than non-CMA infants. In contrast, non-allergic infants
show a Th1-skewed cytokine profile with high production of IFN-γ. At the
development of tolerance, the allergic group shows a Th1-skewed cytokine pattern,
with low levels of IL-4 and high levels of IFN-γ. The age-matched control group
shows a more Th0-like profile with comparable levels of IL-4, IL-5, IL-13 and
IFN-γ.
CMP-specific production of IL-10
To investigate whether the spontaneous development of tolerance after CMA is
accompanied by an increased production of IL-10 by antigen-specific T cells, we
analyzed IL-10 production by the TCCs in this study (Table 5).  IL-10 production
was highly variable in individual TCCs. When compared as a group, the overall
Table 4. Mean cytokine production in infants with AD, with and without CMA, at two timepoints.
Patient group IL-4 (ng/ml) IL-5 (ng/ml) IL-13 (ng/ml) IFN-γ (ng/ml)
CMA pts* 1.90 ± 0.66 9.72 ± 3.69 7.63 ± 2.05 1.93 ± 0.621st
timepoint non-CMA pts* 0.10 ± 0.04 5.52 ± 2.35 4.15 ± 1.54 8.56 ± 3.24
tolerant pts* 0.95 ± 0.55 1.58 ± 1.26 1.87 ± 0.80 4.82 ± 3.822nd
timepoint non-CMA pts* 2.49 ± 1.80 4.32 ± 1.69 2.37 ± 0.78 3.39 ± 3.06
results are expressed as mean ± SEM
*results are based on 3 patients in each group
Table 5. Production of IL-10 by TCCs from infants with AD,
with and without CMA, at two timepoints
PATIENT IL-10 (ng/ml)1st timepoint
IL-10 (ng/ml)
2nd timepoint
Patient I 0.57 0.80
Patient II 1.70 0.01
Patient III 1.45 0.03
Patient IV 4.5 *
Mean 2.05 ± 0.85 0.27 ± 0.26
Control I 3.13 0.01
Control II 0.01 0.62
Control III 2.44 0.08
Control IV 0.12 *
Mean 1.67 ± 0.68 0.23 ± 0.19
* no TCCs obtained at this timepoint
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trend did not show an increase, but a decrease in IL-10 production between the
allergic and tolerant state. In the control group a similar trend was seen with a
decrease in IL-10, which clearly suggests an age-related phenomenon. At both
timepoints, mean TCC production of IL-10 was not different between patients and
controls.
DISCUSSION
Food antigen-specific T cells have been shown to be important in the aetiology of
allergic reactions to foods3,5-8. This has mainly been investigated by studying
differences in T cell reactivity between food-allergic and food-tolerant individuals.
The present study is the first to investigate the role of T cells during the
spontaneous development of tolerance to foods. We compared, at the clonal level,
the antigen-specific T cell response in cow’s milk-allergic individuals during the
allergic phase and after the spontaneous development of tolerance for cow’s milk.
The analysis of cytokine production by the CMP-specific T cells showed marked
differences in the CMP-specific release of the Th2 cytokines at both timepoints.
While the production of IL-4, IL-5 and IL-13 was abundant in the allergic state,
production of these cytokines was decreased after tolerance had developed. At the
same time, an up-regulation in CMP-specific production of IFN-γ was seen. This
resulted in a deviation of the cow's milk-specific T cell cytokine response towards
a Th1-type profile. In contrast, age-matched control patients with AD but without
CMA, showed an opposite phenomenon. During infancy, these patients had a Th1-
skewed CMP-specific cytokine response. In the second year of life, production of
IL-4 increased and IFN-γ decreased, causing a change in the CMP-specific T cell
response towards a more Th0-like cytokine pattern.
The CMP-specific T cell response was investigated at the clonal level in this study.
This makes it possible to investigate the reactivity of antigen-specific T cells
without the disturbance of non-specific T cell reactivity. A disadvantage is that the
elaborate process of establishing antigen-specific T cell clones hampers the
evaluation of large groups of patients.  The TCCs were propagated and activated
using an antigen-specific culture system with autologous B cells as antigen-
presenters, and without the use of non-specific mitogens. We believe that in this
antigen-specific in vitro system, the observed reactivity of T cells is a good
representation of the in vivo reactivity in these patients.
The release of Th2-cytokines by allergen-specific T cells has been shown to be
important in the pathogenesis of allergic reactions9,23,24. They are potent inducers of
allergic inflammation and act through recruitment of leukocytes and the induction
of IgE synthesis25,26. The results from the present study show that the spontaneous
development of tolerance in food allergy is associated with a down-regulation of
these cytokines. This finding supplies further evidence for their importance in the
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aetiology of food allergic symptoms. While a high production of IL-4, IL-5, IL-13
leads to allergic reactions, a low release of these cytokines by antigen-specific T
cells is presumably the reason for the absence of allergic reactions in food-tolerant
individuals.
It has been suggested that fetal and neonatal responses to environmental antigens
such as foods, are initially Th2 in nature, and that these responses deviate to a Th1-
pattern during the first year of life in normal individuals27,28. According to this
view, allergic reactions (in atopic individuals) are caused by an aberrant persistence
of the innate Th2 responses29. Our study shows that in allergy to cow's milk, the
antigen-specific (Th2-) response deviates towards a Th1-response during the
spontaneous development of tolerance. This suggests that if antigen-specific T cell
responses are indeed initially Th2 in nature, then CMA in infancy could be viewed
a result of a temporarily delay in the (normal) redirection of the Th2 response. The
fact that CMA in infancy is remarkably transient, i.e. most patients become tolerant
within 2 years, may support this idea. In this respect, the results from the cytokine
analysis in the non-cow's milk allergic control group in our study are also of
interest. In these patients, the (CMP-specific) Th1-skewed cytokine response that
was present in the first year of life, changed into a Th0-like cytokine pattern. It is
tempting to speculate that during infancy, when cow's milk is first encountered,
persistence of the (fetal) Th2 response leads to allergy, while a vigorous CMP-
specific Th1 response prevents sensitisation for milk antigens. After infancy, when
the ‘window of sensitisation’30,31 has passed by, and allergy to milk has been
successfully prevented, the CMP-specific cytokine response becomes more
balanced (i.e. Th0-like). Further research into the mechanisms that determine T cell
responses during the development of allergy and tolerance to foods, is needed to
confirm this hypothesis.
In patients with allergy to for instance birch-pollen and bee venom, tolerance can
be artificially induced via allergen-specific immunotherapy32,33. It has been shown
that this induction of tolerance is accompanied by a switch from an allergen-
specific Th2-skewed T cell response to a Th1-skewed response34-36. In addition, it
was shown that allergen-specific immunotherapy induces an enhancement of IL-10
production by allergen-stimulated PBMCs32,33. This rise in production of IL-10 is
thought to be caused by an increased IL-10 production by antigen-presenting cells
such as B cells and monocytes37. In the present study, we found no evidence that
spontaneous development of tolerance to food allergens is associated with an
increased production of IL-10 by (food-)antigen-specific T cells. There was a
tendency to a decreased antigen-specific IL-10 production by the TCC, but a
similar decrease was seen in the control group, which suggests an age-related
phenomenon. IL-10 production by antigen-presenting cells was not investigated in
this study. We are therefore unable to determine whether spontaneous development
of tolerance to cow's milk is associated with a rise in IL-10 production by antigen-
presenting cells as occurs during immunotherapy37.
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Cow's milk consists of a number of different proteins. It has been clarified that
allergy to cow's milk is not determined by an immunological response to a
particular cow's milk protein subfraction8,12,38. The CMP-specific T cell clones in
this study were established using a mix of casein- and whey-proteins, the two
predominant protein-fractions in milk38. In the clones that we obtained from the
tolerant patients in our study, we noted an absence of whey-specificity. This was
probably caused by the lower number of clones obtained at this timepoint. In the
age-matched controls, the percentage of established whey-specific TCCs was also
lower, suggesting that T cell reactivity towards whey proteins is less predominant
after infancy. To verify that the absence of whey-specific TCCs did not influence
the conclusions from the cytokine analyses, we also performed all analyses while
leaving out the whey-specific TCC, which showed the same overall result; i.e.
skewing of the cytokine response from a Th2 to a Th1-biased response (data not
shown). This emphasizes that deviation of T cell cytokine profiles and not T cell
reactivity per se determines allergy and tolerance to cow's milk.
In summary, the release of Th2 cytokines by allergen-specific T cells has been
shown to be important in the pathogenesis of food-allergic reactions. In this study
we analyzed, at the clonal level, the cow's milk-specific T cell response in infants
with AD and CMA during the spontaneous development of tolerance for cow's
milk. We found that cow's milk-specific production of IL-4, IL-5 and IL-13, which
was abundant during the allergic phase, had decreased after the development of
tolerance, while at the same time IFN-γ production was up-regulated. This resulted
in a deviation of the CMP-specific T cell cytokine response towards a Th1-type
profile. These findings supply further evidence for the importance of T cell
cytokine profiles in the aetiology of allergy and tolerance to food-antigens.
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cow’s milk allergic infants
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ABSTRACT
Background The release of Th2 cytokines by food-specific T cells is thought to
be important in the etiology of food allergy. It has been suggested that the
activation state of food-specific T cells also plays a significant role, but this has not
yet been studied at the single cell level.
Objective To evaluate differences in the expression of cell-surface markers
by cow’s milk protein (CMP)-specific T cells between infants with and without
cow’s milk allergy (CMA) at the clonal level. In addition, changes during the
spontaneous development of tolerance for cow’s milk in infants with CMA were
analyzed.
Methods We established CMP-specific T cell clones (TCCs) from blood of
infants with CMA and atopic dermatitis (AD), from atopic controls with AD but
without CMA, and from non-atopic controls. In addition, we established TCCs
from the infants with CMA after they had spontaneously developed tolerance to
CM. Expression levels of CD25, CD26, and CD30 by each TCC were analyzed by
flow cytometry.
Results CMP-specific T cells from infants with CMA expressed much
higher levels of CD25 and CD30 than CMP-specific T cells from infants without
CMA. Expression of CD26 was much lower than in normal controls. After the
development of tolerance for CM, expression of CD25 and CD30 was decreased,
while the expression of CD26 was increased to normal levels.
Conclusion Antigen-specific T cells from patients with food allergy display an
increased expression of cell-surface markers of activation, compared with patients
without food allergy. This suggests an intrinsically stronger food-specific T cell
response in food-allergic patients, and points to the key role of food-specific T cells
in the pathogenesis of food allergy.
INTRODUCTION
Food antigens are the main allergens causing allergic reactions during infancy and
childhood1,2. An important role in the pathogenesis of food allergy is attributed to
food-specific T cell reactivity. Both in allergen-stimulated PBMCs3-6, and at the
clonal level7 it has been shown, that the food-specific T cell response in patients
with food allergy is Th2-skewed compared with food-tolerant individuals. As the
Th2-cytokines (IL-4, IL-5 and IL-13) are important in the pathogenesis of allergic
inflammation8,9, these results have suggested a key role for allergen-specific T cells
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in food allergy-related symptoms.
There are observations which suggest that not only production of Th2 cytokines,
but also the activation state of food-specific T cells might play a role in the
pathogenesis of food allergy. Food-specific T cell reactivity is present in food-
allergic and food-tolerant individuals, but proliferative responses of T cells in
patients with food allergy are higher than in food-tolerant patients10-14. In addition,
patients with allergic disease have higher numbers of circulating, activated
allergen-specific T cells bearing activation markers such as CD25 and CD3015-18.
These studies however, investigated T cell reactivity in bulk cultures of T cells,
which makes it difficult to extrapolate results to the individual T cell.
An important marker of T cell activation is CD25 (IL-2Rα), the high affinity
receptor for IL-219. CD30, a member of the tumor necrosis factor, is another
marker for the activation state of a T cell20. The expression of CD30 by T cells has
been associated with the preferential production of Th2 cytokines21,22. Similarly,
the expression of CD26 (dipeptidyl-peptidase IV) by T cells has been associated
with Th1 responses23,24. So far, no study has investigated the expression of these
cell-surface markers by food-specific T cells at the single cell level.
Cow’s milk is the most important food antigen in young children, and is the
aetiological factor of cutaneous symptoms in approximately 35-40% of infants with
atopic dermatitis (AD)25,26. Cow's milk allergy (CMA) in infancy is associated with
the spontaneous development of tolerance within 2-3 years2. The aim of this study
was to investigate the cow’s milk protein (CMP)-specific T cell response in
patients with CMA and AD at the clonal level, by analyzing levels of expression of
cell-surface markers by the CMP-specific T cells in these patients. We used an
antigen-specific T cell-culturing system with autologous B cells as antigen-
presenting cells to establish CMP-specific T cell clones (TCCs) from blood.
Expression of CD25, CD26, and CD30 by T cells derived from blood of infants
with CMA was compared with CMP-specific T cells from age-matched control
infants without CMA. In addition, we investigated changes during the spontaneous
development of tolerance for cow’s milk in infants with CMA.
METHODS
Patients & control subjects
The CMP-specific TCCs described in this study were derived from blood of 5
infants with CMA and AD, and from 4 atopic control infants with AD, but without
CMA. These infants have been described elsewhere7. CMA was diagnosed by
complete elimination of cow's milk from the infant's diet, followed by a cow's milk
challenge. As non-atopic controls, 3 infants prior to cardiac surgery, in the absence
of hemodynamic compromise were included. These infants did not have any atopic
disorders (eczema, asthma or rhinitis), did not have increased total IgE levels, and
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were not sensitized for a panel of 12 common inhalation and food allergens as
determined by CAP system FEIA (Pharmacia Diagnostics, Uppsala, Sweden).
They did not use systemic or topical immunomodulatory drugs. The three groups
of infants were matched with regard to age, CMA patients: 4.5 – 10.4 months
(mean 7.4); atopic controls: 6.1 - 7.4 months (mean 7.0); non-atopic controls: 6.4 -
9.9 months (mean 8.0).
In addition, CMP-specific TCCs were established from 3 of the infants with AD
and CMA after they had spontaneously outgrown their CMA (age: 21.9-32.3
months, mean 26.5). To control for age-related changes, CMP-specific TCCs from
3 of the infants with AD but without CMA at the same age (age; 19.8-38.3 months,
mean 26.0) were also established.
All blood samples were taken after informed consent was obtained, and the study
was approved by the Medical Ethical Committee of the University Medical Center,
Utrecht.
Reagents
A mix of purified CMPs (CMP-mix) containing equal quantities of total casein, α-
lactalbumin and β-lactoglobulin (each at a concentration of 50 µg/ml) was used as
antigen. Purified CMPs were kindly provided by Dr. E.C.H. van Beresteijn
(Netherlands Institute for Dairy Research, Ede, The Netherlands). For culturing of
T cell lines and TCCs, complete medium RPMI-1640 (Gibco, New York, USA)
was used, supplemented with 10% pooled human AB serum. Epstein Barr virus
(EBV)-transformed B cells were cultured in RPMI-1640 (Gibco), supplemented
with 10% fetal calf serum (Gibco). Established TCCs were maintained in Iscove’s
Modified Dulbecco’s Medium (Gibco) supplemented with 2% pooled human AB
serum and 5% Yssel's medium. All media were supplemented with penicillin (100
IU/ml), streptomycin (100 mg/ml) and glutamin (1 mM) (Gibco).
Preparation of CMP-specific TCCs
CMP-specific TCCs were established as described previously7,27. PBMCs were
isolated from heparinized venous blood, and subsequently cultured in the presence
of CMP-mix. After 7 days, 50 IU/ml of both recombinant IL-2 and IL-4 (kind gift
of Novartis Research Institute, Vienna, Austria) was added to the culture medium.
Cultures were re-stimulated every 14 days with irradiated (50 Gy) autologous
EBV-transformed B cells that had been pre-incubated O/N with CMP-mix, as
antigen-presenting cells. If these cultures indicated a high CMP-specific T cell
proliferation in lymphocyte stimulation test (LST), T cells were cloned by limiting
dilution, in the presence of IL-2, IL-4 and irradiated autologous EBV-transformed
B cells (104/well) that had been pre-incubated O/N with CMP-mix. All established
TCCs were tested in LST to verify CMP-specificity.
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Flow-cytometric analysis
Expression of CD4, CD8, TCR, CD25, CD26 and CD30 by the TCCs was
analyzed by flow cytometry, 2 days after a re-stimulation with irradiated
autologous EBV-transformed B cells that had been pre-incubated O/N with CMP-
mix. Antibodies used were: fluorescein isothiocyanate (FITC)- conjugated mouse-
anti-human CD4 (clone Leu-3a, BD Biosciences, San Jose, USA), phycoerythrine
(PE)-conjugated mouse-anti-human CD8 (clone Leu-2a, BD Biosciences), FITC-
conjugated mouse-anti-human α/β TCR (clone WT-31, BD Biosciences), FITC-
conjugated mouse-anti-human CD25 (clone M-A251, BD Biosciences), PE-
conjugated mouse-anti-human CD26 (clone M-A261, BD Biosciences), and FITC-
conjugated mouse-anti-human CD30 (clone BerH8, BD Biosciences). Cells were
stained, fixed in paraformaldehyde, and analyzed with FACScan (BD Biosciences).
All clones were CD4+ and expressed the α/β TCR (data not presented). Expression
levels of CD25, CD26, and CD30 by each TCC was measured as mean
fluorescence intensity (MFI). Isotype-matched control antibodies were used to
control for non-specific binding.
CMP-specific cytokine release
CMP-specific cytokine release by the TCCs was determined as described
previously7. To determine CMP-specific cytokine release, 106 cells of each TCC
were incubated with 106 irradiated autologous EBV-transformed B cells that had
been pre-incubated O/N with CMP-mix. Control cultures of TCCs and EBV-
transformed B cells, pre-incubated without antigen were prepared in parallel.
Cytokines (IL-4, IFN-γ) were measured by ELISA according to the manufacturers
recommendations (Central Laboratory of the Blood Transfusion Service,
Amsterdam, The Netherlands).
Statistical analysis
Parametric analysis (Student’s t-test) was applied to determine significant
differences between patient and control groups with regard to age, mean MFI, and
differences in cytokine production. Differences associated with p values of less
than 0.05 were considered significant. Parametric analysis (Pearson’s correlation)
was used to test for correlation between expression of different cell-surface
markers, and between surface marker expression and cytokine production.
RESULTS
Differences in expression of cell-surface markers by CMP-specific T cells from
infants with CMA and controls
Differences in expression of CD25, CD26, and CD30 by TCCs derived from
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infants with CMA and AD (n=13), TCCs from atopic control infants without CMA
(n=37), and TCCs from non-atopic control infants without CMA (n=74) were
analyzed. Figure 1 shows MFI of CD25, CD26, and CD30 expression on CMP-
specific TCCs derived from the three patient groups.  Mean expression of CD25
was significantly higher on TCCs derived from infants with CMA compared with
TCCs from infants without CMA (p<0.05). This accounted for both the atopic
controls and the non-atopic controls. Expression of CD30 was also significantly
higher on TCCs derived from infants with CMA, compared with TCCs from both
control groups (P<0.05). In contrast, mean expression of CD26 was lower in
infants with CMA, compared with non-atopic infants without CMA (p<0.05).
Comparison of both control groups showed that atopic infants without CMA had
comparable expression of CD25, but a higher expression of CD30 and a lower
expression of CD26 than non-atopic controls.
Changes during the development of tolerance in patients with CMA
Expression of CD25, CD26 and CD30 on TCCs (n=18) derived from infants with
CMA after they had spontaneously developed tolerance for CMP was analyzed,
and compared with TCCs derived from these infants during the allergic state. In
addition, TCCs (n=39) from age-matched atopic control infants were investigated.
Figure 2 shows MFI of expression of CD25 (Figure 2A), CD26 (Figure 2B), and
CD30 (Figure 2C) on CMP-specific TCCs derived from the infants with CMA
before and after the development of tolerance, and from the age-matched atopic
controls at both timepoints. The non-atopic infants at the first timepoint are shown
as reference. There was a significant decrease in the mean expression of CD25 on
Figure 1. Mean fluorescence intensity of CD25-, CD26-, and CD30-expression by CMP-
specific TCCs derived from infants with CMA and AD, age-matched atopic control patients
with AD but without CMA, and age-matched non-atopic controls. Expression was measured
by using flow cytometry, 2 days after stimulation with CMPs. *: p<0.05 (Student’s t-test).
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CMP-specific TCCs derived from the infants with CMA after they had developed
tolerance to cow’s milk, compared with TCCs derived from these infants during
the allergic state. The same was true for the expression of CD30, which was high
during the allergic state, and had significantly decreased after the development of
tolerance. In contrast, mean expression of CD26, which was low during the allergic
state, increased at the development of tolerance. At the tolerant state, the
expression of CD25 by CMP-specific TCCs from infants with CMA was still
higher than the non-atopic controls who had never had CMA. For CD26 and CD30,
expression levels between both groups were comparable.
CMA+/AD+ patients (T1)
CMA-/AD+ controls (T1)
non-atopic controls (T1)
Tolerant patients (T2)
CMA-/AD+ controls (T2)
Figure 2. Mean fluorescence intensity of expression of CD25 (A), CD26 (B) and CD30 (C)
by CMP-specific TCCs derived from infants with CMA and AD, before and after the
development of tolerance for CMA, and age-matched atopic-control patients with AD without
CMA at both timepoints. Non-atopic control infants from the first timepoint are shown as
reference. T1 = first timepoint (before tolerance), T2 = second timepoint (after tolerance).
Expression was measured by using flow cytometry, 2 days after stimulation with CMPs. *:
p<0.05 (Student’s t-test).
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Correlation between expression of different cell-surface markers
The relation between the antigen-specific expression of the different cell-surface
markers on the CMP-specific TCCs described in this study was investigated.
Results showed that the expression of CD25 and CD30 was significantly correlated
(r = 0.668, p<0.01) in all TCCs investigated in this study (Figure 3A). There was a
negative correlation (r = -0.241, p<0.01) between the expression of CD26 and
CD30 in all TCCs (Figure 3B). No significant correlation was observed between
the expression of CD25 and CD26 (data not shown).
Relation between expression of CD26/CD30 and production of Th1/Th2-
cytokines
To investigate whether the relationship between the expression of CD26 and CD30
is associated with the production of Th1/Th2 cytokines in the TCCs described in
this study, the correlation between the expression of CD26 and CD30 and the
production of IL-4 and IFN-γ was calculated. Results showed no significant
correlation between the expression of CD26 and IFN-γ (Figure 4A), or between the
expression of CD30 and IL-4 (Figure 4B). In addition, we found no significant
correlation between the expression of CD30 and the production of IFN-γ, or
between the expression of CD26 and the production of IL-4 (data not shown).
DISCUSSION
Food antigen-specific T cells are important in the aetiology of allergic reactions to
foods1. It has been shown that food-specific T cells from food-allergic and food-
tolerant individuals differ greatly with regard to the production of Th1 and Th2
Figure 3. Correlation between expression of CD25 and CD30 (A), and between expression
of CD26 and CD30 (B) by the CMP-specific TCCs investigated in this study. Expression was
measured by using flow cytometry, 2 days after stimulation with CMPs.
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cytokines3-7. In this study, we analyzed differences in food-specific T cell reactivity
with regard to expression of cell-surface markers.
The results from our study show at the clonal level, that food-specific T cells from
patients with food allergy express much higher levels of CD25 than food-specific T
cells from patients without food allergy. CD25 (IL-2Rα) expression is regulated by
IL-2, the major T cell growth factor, and is therefore an important marker for the
activation state of a T cell19. The fact that the food-reactive T cells from food-
allergic patients have a much higher expression of the receptor for IL-2, suggests
that the antigen-specific T cell response in these patients is more pronounced than
in patients without food allergy. From investigations in PBMCs it is known that
food-specific T cells from patients with allergy to food have a higher proliferative
capacity in vitro than cells from non-food allergic patients10-14. This suggests that
the in vivo food-specific T cell response in patients with food allergy is intrinsically
more vigorous. Our finding that allergen-specific T cells from infants with food
allergy obtain a higher state of activation, might explain the food-allergic state of
these patients. In this respect, the findings in the patients that had become
spontaneously tolerant after cow’s milk allergy are also of interest. We showed that
in TCCs derived from these patients, the expression of CD25 is significantly lower
than at the allergic state, whereas no change occurred in age-matched atopic
controls, again suggesting that high CD25 expression by allergen-specific T cells
and allergic state might be connected.
Determination of CD30 expression by the TCCs in our study confirmed the results
of the expression of CD25. Analysis of expression of CD30 showed that antigen-
specific T cells from cow’s milk-allergic patients have a higher CD30 expression
Figure 4. Correlation between expression of CD26 and production of IFN-γ (A), and
expression of CD30 and production of IL-4 (B) by the CMP-specific TCCs investigated in this
study. No significant correlations exist. Expression was measured by using flow cytometry, 2
days after stimulation with CMPs. Cytokine production was measured in culture
supernatants 24 hours after stimulation with CMPs
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than T cells from non-cow’s milk allergic patients. The expression of CD30 by
CMP-specific T cells from patients that had spontaneously developed tolerance
was significantly lower than at the allergic state. These results from CD30 as
marker for the activation state of T cells are comparable with the results of the
CD25 expression, and indicate an enhanced activated state of T cells in patients
with allergic symptoms. Indeed, analysis of the expression of CD25 and CD30
showed a significant positive correlation between expression of the two markers.
Our study shows that expression of CD26 by CMP-specific T cells from patients
with CMA and AD is significantly lower than in normal controls. After the
development of tolerance for cow’s milk, CD26 expression increases, and returns
to levels comparable with normal controls. Expression of CD26, the receptor for
adenosine deaminase, by T cells is important for co-stimulatory signals, but its
precise physiological role is unknown28,29. Several studies have shown that absence
or low levels of CD26 on T cells mediates immunological diseases28-31. It is
therefore tempting to speculate that low expression of CD26 by allergen-specific T
cells from patients with food allergy contributes to the allergic state of these
patients.
The expression of CD26 by T cells has been described to be preferentially
associated with the release of Th1-cytokines23,24. Similarly, the expression of CD30
by T cells has been associated with Th2-mediated disease21,22. These associations
have even led to the proposal for CD26 and CD30 as exclusive markers for Th1-
and Th2-cells respectively32. Several subsequent studies however, have shown that
expression of CD26 and CD30 is variable, and can be expressed by T cells on both
ends of the Th1-Th2 spectrum, as well as Th0 cells33-37. We investigated the
relation between the expression of CD30 and CD26, and the production of IL-4 and
IFN-γ, the hallmark Th2-Th1 cytokines, in the TCCs described in our study. We
found no correlation between the expression of CD30 and production of IL-4, nor
between the expression of CD26 and IFN-γ production. In addition, we observed
no association between CD30 and IFN-γ production, nor between CD26 expression
and IL-4 release. These results with a large number (n=181) of TCCs confirm that
on the level of the individual T cell, CD30 and CD26 can not be used as exclusive
markers for Th2- and Th1-cells33,35,36.
Interestingly, we noticed differences in the expression of CD26 and CD30 by T
cells from the atopic and non-atopic control patients. Despite the fact that the
atopic controls did not have CMA, the CMP-specific T cells showed a higher
expression of CD30, and a lower expression of CD26 compared with non-atopic
controls. This indicates that expression of these markers by T cells may reflect the
atopic state of a patient. It has been shown that expression of CD30 is generally
increased in atopic disease, both on the cell surface of T cells38,39, as well as release
of its soluble counterpart40,41. Studies that investigated CD30 expression on T cells
however, mostly investigated differences in numbers of CD30-positive T cells. Our
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study now shows that expression levels of CD30 on individual T cells are also
increased in atopic disease. The exact immunological functions of CD26 and CD30
remain unknown, further studies therefore are needed to clarify the exact role of
CD26 and CD30 in allergy and atopic disease.
In summary, it has been established that patients with food allergy have an antigen-
specific Th2-skewed T cell response compared with food-tolerant patients. The
results from the present study show that, following stimulation, antigen-specific T
cells from patients with food allergy display an increased expression of cell-surface
markers of activation, compared with patients without food allergy. This suggests
an intrinsically stronger response of food-specific T cells in food-allergic patients,
and points to the key role of food-specific T cells in the pathogenesis of food
allergy.
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The level of CLA expression, and not CLA per se,
determines the localization of allergen-specific T cells
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ABSTRACT
Background Cutaneous lymphocyte antigen (CLA) is a cell surface protein that
is proposed to play a role in the specific homing of circulating allergen-specific T
cells to the skin. This hypothesis has mainly been addressed by assessing
differences between skin and blood of patient and control groups with regard to
numbers of CLA-positive T cells.
Objective To investigate the role of CLA in the context of CMA and AD,
CLA expression was measured on T cells at the single cell level.
Methods Cow’s milk protein (CMP)-specific T cell clones (TCCs) were
established from blood of infants with cow’s milk allergy (CMA) and atopic
dermatitis (AD), and from age-matched controls without CMA. In addition, TCCs
from skin and blood of older children with AD were compared. For each TCC,
CLA expression after stimulation with CMP was analyzed by using flow
cytometry.
Results CLA expression by CMP-specific TCCs in blood of infants with
AD and CMA was not significantly different from infants without CMA; mean
MFI resp. 29.7 ± 7.0 vs 26.1 ± 3.2. However, CLA expression on TCCs derived
from skin of infants with AD was much higher than on TCCs from blood of these
infants (mean MFI 280 ± 72 vs 56 ± 12, p<0.0001).
Conclusion CLA expression by allergen-specific T cells in blood of patients
with allergen-induced skin symptoms is comparable to non-allergic infants when
examined at the single cell level, which argues against an increased skin-homing
potential. The finding that T cells in skin of patients with AD express much higher
levels of CLA than T cells from blood, however, might indicate that CLA
expression is important for the retention of allergen-specific T cells in the skin.
INTRODUCTION
Cutaneous lymphocyte antigen (CLA) is a cell surface protein that is expressed by
T cells, and which is thought to be important for their selective migration to the
skin1-3. Expression of CLA by a T cell aids in the migration to cutaneous sites
through interactions with E-selectin, which facilitates the process of ‘tethering and
rolling’ that is needed for extravasation4-6. It is proposed that CLA expression is the
imperative signal for the T cell to selectively migrate to the skin, and CLA is
therefore often referred to as the ‘skin-specific homing marker’3,7,8.
Several studies have shown an important role for CLA-expressing T cells in the
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aetiology of allergic skin symptoms9-15. It was shown that in patients with atopic
dermatitis and allergy to environmental allergens, allergen-specific T cells are
predominantly CLA-positive, in contrast to T cells from non-allergic individuals9-
11. Furthermore, it was shown that in skin of patients with allergic skin disease, the
numbers of CLA-expressing T cells are higher than in blood, and are much higher
than in skin of normal controls12,13. The finding that patients with allergic lung
disease have virtually no antigen-specific T cells that express CLA, both in blood
and at pulmonary sites, further established the role of CLA in the skin-specific
homing of T cells14,15.
However, the role of CLA expression by T cells has so far been mainly addressed
by assessing differences between skin and blood of patient and control groups with
regard to numbers of CLA-positive T cells. Few studies have investigated levels of
CLA expression on individual T cells16-18. The aim of this study was to analyze the
cell-surface expression of CLA at the single cell level. An antigen-specific T cell
culturing system with autologous B cells as antigen-presenting cells was used to
establish cow’s milk protein (CMP)-specific T cell clones (TCCs). Differences in
levels of CLA expression by CMP-specific TCCs derived from blood of infants
with cow’s milk allergy (CMA) and atopic dermatitis (AD), infants with AD
without CMA, and non-atopic controls without AD were analyzed. In addition,
differences in CLA expression by TCCs derived from skin and blood of  children
with AD were studied.
METHODS
Patients and control subjects
The CMP-specific TCCs described in this study were derived from blood of 5
infants with CMA and AD, and from 4 atopic control infants with AD, but without
CMA. These infants have been described elsewhere19. CMA was diagnosed by
complete elimination of cow's milk from the infant's diet, followed by a cow's milk
challenge20. Infants that developed symptoms during challenge that disappeared
during subsequent elimination were diagnosed with CMA. Infants without CMA
did not have any reactions, and no significant change in the severity of the eczema
was noted throughout the entire elimination-provocation period. As non-atopic
controls, 3 infants prior to cardiac surgery, in the absence of hemodynamic
compromise were included.
Atopy was excluded by negative family history, absence of clinical atopic disorders
(eczema, asthma or rhinitis), and by in vitro diagnostics: infants did not have
increased total IgE levels, and were not sensitized for a panel of 12 common
inhalation and food allergens as determined by CAP system FEIA (Pharmacia
Diagnostics, Uppsala, Sweden). No systemic or topical immunomodulatory drugs
were used. The three groups of infants were matched with regard to age, CMA
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patients: 4.5 – 10.5 months (mean 7.5); atopic controls: 6.0 - 7.5 months (mean
7.0); non-atopic controls: 6.5 - 10 months (mean 8.0).
Furthermore, to investigate differences between CMP-specific T cells in blood and
skin, we established CMP-specific TCCs from blood and skin of 4 older children
with AD (age: 22.0-38.5 months, mean 28.0). All 4 children were tolerant for
cow’s milk as proven by a cow’s milk challenge.
All blood and skin samples were taken after informed consent was obtained, and
the study was approved by the Medical Ethical Committee of the University
Medical Center, Utrecht.
Reagents
A mix of purified CMPs (CMP-mix) containing equal quantities of total casein, α-
lactalbumin and β-lactoglobulin (each at a concentration of 50 µg/ml) was used as
antigen. Purified CMPs were kindly provided by Dr. E.C.H. van Beresteijn
(Netherlands Institute for Dairy Research, Ede, The Netherlands). For culturing of
T cell lines and TCCs, complete medium RPMI-1640 (Gibco, New York, USA)
was used, supplemented with 10% pooled human AB serum. Epstein Barr virus
(EBV)-transformed B cells were cultured in RPMI-1640 (Gibco), supplemented
with 10% fetal calf serum (Gibco). Established TCCs were maintained in Iscove’s
Modified Dulbecco’s Medium (Gibco) supplemented with 2% pooled human AB
serum and 5% Yssel's medium. All media were supplemented with penicillin (100
IU/ml), streptomycin (100 mg/ml) and glutamin (1 mM) (Gibco).
Preparation of CMP-specific TCCs
CMP-specific TCCs were established from blood and skin as described
previously19,21. To establish TCCs from blood, PBMCs were isolated from
heparinized venous blood, and subsequently cultured in the presence of CMP-mix.
After 7 days, 50 IU/ml of both recombinant IL-2 and IL-4 (kind gift of Novartis
Research Institute, Vienna, Austria) was added to the culture medium. Cultures
were re-stimulated every 14 days with irradiated (50 Gy) autologous EBV-
transformed B cells that had been pre-incubated O/N with CMP-mix, as antigen-
presenting cells. If these cultures indicated a high CMP-specific T cell proliferation
in lymphocyte stimulation test (LST), T cells were cloned by limiting dilution, in
the presence of IL-2, IL-4 and irradiated autologous EBV-transformed B cells
(104/well) that had been pre-incubated O/N with CMP-mix22.19
To establish CMP-specific T cells from skin biopsies, a single-cell suspension was
prepared from skin by enzymatic digestion according to the method described by
Sager et al.23. Culture of recovered cells was started in a 48-well flat bottom culture
plate in the presence of CMP-mix, IL-2, IL-4, and irradiated autologous PBMCs
(106/well) as feeders. The cultures were maintained and tested as described for
blood-derived TCCs. All established TCCs were tested in LST to verify CMP-
specificity.
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Flow-cytometric analysis
Expression of CLA by the TCCs was analyzed by flow cytometry, 2 days after a
re-stimulation with irradiated autologous EBV-transformed B cells that had been
pre-incubated O/N with CMP-mix. Antibodies used were: CLA (HECA 452, kind
gift of Prof. Dr. R. Scheper, Free University of Amsterdam, Amsterdam, The
Netherlands). Unlabeled CLA was detected by phycoerythrine-conjugated goat-
anti-rat IgM (Immunotech, Marseille, France). Cells were stained, fixed in
paraformaldehyde, and analyzed with FACScan (BD Biosciences). Results were
expressed as mean fluorescence intensity (MFI). Expression levels of CLA by each
TCC was measured as mean fluorescence intensity (MFI). Isotype-matched control
antibodies were used to control for non-specific responses.
Statistical analysis
Parametric analysis (Student’s t-test) was applied to determine significant
differences between patient and control groups with regard to age, and differences
in mean MFI. Differences associated with p values of less than 0.05 were
considered significant.
RESULTS
CLA expression by CMP-specific T cells in blood of infants with and without
CMA
The expression of CLA (MFI) was analyzed on TCCs derived from blood of
infants with CMA and AD (n=13), TCCs from atopic control infants with AD, but
without CMA (n=37), and TCCs from non-atopic control infants without CMA
(n=74). CLA expression, measured as MFI, was generally low on CMP-specific T
Figure 1. Mean expression of CLA on
CMP-specific T cells in blood of infants
with CMA and AD (closed bars), age-
matched atopic controls without CMA
(hatched bars), and non-atopic controls
without CMA (open bars). *: p<0.05
(Student’s t-test). NS = not significant.
CMA-CMA+
ns
m
ea
n 
flu
or
es
ce
nc
e 
in
te
ns
ity
Chapter 6
82
cells derived from blood. Figure 1 shows mean MFI of CLA expression by CMP-
specific TCCs derived from the three patient groups. When these subgroups were
analyzed separately, results from infants with CMA and AD were comparable with
normal controls whereas results from atopic controls were significantly lower than
the other 2 groups. When expression of CLA by CMP-specific T cells from infants
with CMA (mean MFI: 29.7 ± 7.0) was compared with CLA expression of all
TCCs derived from infants without CMA (mean MFI: 26.1 ± 3.2), no significant
differences were found.
Differences in CLA expression between CMP-specific T cells in blood and skin
To investigate differences in expression of CLA between T cells in blood and skin
of patients with AD, CMP-specific TCCs derived from blood (n=57) and skin
(n=38) of children with AD (mean age: 28.0 months) were compared. Results of
flow-cytometric analysis showed significant differences in CLA expression
between T cells from skin and blood. Representative examples of 2 patients are
shown in Figure 2. Mean CLA expression on T cells derived from skin was more
than 5-fold higher than expression on blood T cells (Figure 3).
Figure 2. Representative results of flow-cytometric analysis of CLA expression on CMP-
specific T cells in blood and skin of two children with AD.
128128
128128
100 101 102 103 104
00
00
1010 00 1010 11 1010 22 1010 33 1010 44
100 101 102 103 104
Blood Skin
Level of CLA-expression
83
DISCUSSION
Allergen-specific T cells have been shown to be important in the aetiology of
allergic reactions24-27. The expression of CLA by allergen-specific T cells is
thought to be important for selective migration to the skin in patients with allergic
skin disease1-3. This hypothesis has mainly been investigated by assessing
differences between skin and blood of individuals with or without allergic skin
disease with regard to numbers of CLA-expressing T cells9-11,28. In the present
study, differences in the level of CLA expression by allergen-specific T cells from
patients and controls were analyzed at the single cell level.
CMP-specific T cells from infants with CMA and AD were investigated. The
results showed that CLA expression by allergen-specific T cells in blood of infants
with CMA is not significantly different from CLA expression in non-atopic infants
without CMA. A significant lower CLA expression was found in atopic control
patients without CMA. However, as compared to the expression observed on skin
TCCs, the level of CLA expression on blood TCCs is low in all 3 groups of infants.
This, in addition to the fact that no differences exist between infants with CMA and
non-atopic infants without CMA, questions the relevance of the significant lower
expression in the atopic controls. Therefore, in our opinion, results show that CLA
expression in blood is essentially comparable in all infants. This might indicate that
the skin-homing potential of blood-derived T cells from allergic and non-allergic
individuals is not different. Previous findings did suggest differences in skin-
homing capacity between allergen-specific T cells from allergic and non-allergic
individuals2,9,10. Abernathy-Carver and co-workers investigated children with CMA
and allergic skin symptoms, and found that allergen-specific proliferative T cell
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Figure 3. Mean expression of CLA on
CMP-specific T cells in blood and skin
of children with AD.
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responses in these children are dominated by CLA-expressing T cells, in contrast to
children who do not have cow’s milk-induced skin symptoms9. Similar results were
found when patients with allergy to environmental allergens were investigated2,10.
However, these studies all evaluated differences in numbers of CLA-expressing T
cells, rather than investigating the level of CLA expression by the disease-related T
cells at the individual cell level. Until now, no study compared levels of CLA on
isolated T cells from patients with and without allergy. Our study clearly shows
that, at the single cell level, disease-related T cells in patients with allergic skin
disease do not differ in CLA expression when compared to T cells from individuals
without allergic skin disease. The previous suggested differences in skin-homing
capacity of the allergen-specific T cells from (food) allergic and non-allergic
individuals, must therefore be attributed to differences in numbers of CLA-
expressing T cells, rather than to intrinsic differences in skin-homing capacity of
the individual cells.
To investigate differences in expression of CLA between circulating T cells and T
cells that reside in the skin, TCCs from blood and skin of older children with AD
were established. Analysis of CLA expression by these TCCs showed that T cells
from skin have a higher expression of CLA than T cells from blood. Expression of
CLA on T cells from skin was on average approximately five times as high as CLA
expression on blood T cells, and there was virtually no overlap between levels of
CLA expression by skin and blood T cells (Figures 2 and 3). These findings
indicate intrinsic differences in CLA expression by T cells in the blood and those
that reside in the skin. Only 2 previous studies have evaluated levels of CLA
expression on skin derived T cells16,17. Rossiter et al. investigated T cells from
patients with allergy to house dust mite and showed that the allergen-specific T
cells in skin of these patients expressed a much higher level of CLA compared with
T cells from blood of these patients17. The same results were found when T cells
from blood and skin of patients with delayed type hypersensitivity were
investigated 16. The results from our study now confirm these findings for food
allergen-specific T cells in young children.
Taken together, findings from both this study and the literature show that there are
intrinsic differences between levels of CLA expression by T cells in blood and
those that reside in the skin. It is tempting to speculate that these differences in
CLA expression determine the localization of allergen-specific T cells, either in the
circulation or in the skin. The expression of CLA by T cells is thought to be helpful
in the migration of T cells to cutaneous sites. It was shown that expression of CLA
by T cells is not restricted to predefined T cell subsets, but is variable in vivo, and
can be regulated by local tissue factors6,18. Previous studies, who showed that CLA
is not an absolute prerequisite for blood T cells to extravasate into cutaneous
sites29,30 therefore suggested that CLA may be upregulated on T cells in skin after
local activation16,31. It was suggested that expression of CLA by T cells is more
important for the retention of specific T cells in the skin, rather than the process of
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extravasation itself29. The observed differences in CLA-levels between blood- and
skin-T cells suggest, that the level of CLA that is expressed by the T cell might be
relevant in this issue. During allergen-specific immune surveillance, it is important
that T cells stay in the skin, to mediate the tissue-specific immune response3. It is
possible, that the (low) expression of CLA by allergen-specific T cells in blood is
further upregulated after they have entered the skin, to facilitate the retention of
these cells in the skin. The regulation of CLA by local tissue factors might play an
important role in this process6,18,32. Future studies should therefore be focused on
the regulation of levels of CLA expression, to elucidate the exact function of CLA
expression by skin-homing T cells.
In summary, levels of CLA expression by allergen-specific T cells in blood of
individuals with and without food allergy are comparable, suggesting that the skin-
homing potential of circulating T cells from allergic and non-allergic individuals is
not intrinsically different. However, T cells in skin of patients with AD express
much higher levels of CLA than T cells in blood, suggesting intrinsic differences
between CLA expression of T cells in the blood and those that reside in the skin.
These results provide additional support for the critical role of CLA in the T cell
localization in the skin, and suggest that differences in levels of CLA may be
important for the retention of T cells in the skin.
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ABSTRACT
Background Screening for food-specific sensitization using in vitro and/or skin
tests has become an essential step in the diagnostic work-up of children with
suspected food allergy.
Aim The aim of our study was twofold: to study patterns of sensitization
for cow’s milk, hen’s egg and peanut in children referred to a tertiary hospital for
suspected food allergy. In addition, we compared the screening for food-specific
sensitization using in vitro IgE detection and skin prick testing in these children.
Methods We evaluated a cohort of 785 children referred to our pediatric
allergy outpatient clinic for suspected food allergy. All patients were screened for
food-specific sensitization by using in vitro IgE detection, and skin prick tests.
Sensitization was established when at least one of both tests showed a positive
result.
Results The most common allergen in the total group was hen’s egg, with
51% of the referred children being sensitized. In children <4 years was hen’s egg
the most frequent allergen, in children >4 peanut. Comparison of screening-results
in all sensitized children showed that the proportion of sensitized patients with a
positive result in both in vitro- and skin test, was 56% at most. This means, that a
large part of the sensitized children would have been missed if only one of both
tests had been used for screening.
Conclusions The results from this study show a substantial mismatch between
the outcome of in vitro IgE detection and skin prick testing when screening for
food-specific sensitization in children with suspected food allergy. Screening for
food-specific sensitization in the pediatric age group should therefore be performed
using both in vitro IgE detection as well as skin prick testing, to prevent false-
negative results.
INTRODUCTION
Food allergy is the most common allergy during infancy and childhood1,2. It is
estimated that 2-8% of all infants and young children have adverse reactions to
foods3-7. The predominant food allergens are cow’s milk, hen’s egg, peanut and to
a lesser extent soy. These allergens may induce a repertoire of symptoms, such as
acute effects in the lung or skin, but may are also associated with more chronic
disease such as atopic dermatitis2.
The diagnostic work-up of food allergy in children has gained more attention in the
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recent years8-10. After the suspected food has been identified by examining the
patients medical history, the golden standard to diagnose clinical relevant food
allergy is a provocation with the food in question. This challenge is preferably
performed using a double-blind, placebo-controlled protocol (DBPCFC), as this is
the most objective method to diagnose food-induced symptoms11. However,
because of the time, expense, and discomfort to the patient, it is often not possible
to examine large numbers of foods using a challenge procedure. It is therefore
common practice to screen for food-specific sensitization using in vitro and/or skin
prick testing8,10,12. These methods, which are not time-consuming to the patient,
establish the presence of IgE-antibodies to the food, indicating a food-specific
immune reaction. This establishes the need for a provocation with the food, to
determine clinically relevant food allergy. Screening for food-specific sensitization
using in vitro and/or skin tests thus provides guidance for selecting food for
DBPCFCs, and has therefore become an essential step in the diagnostic work-up of
children with suspected food allergy1,10.
In this study we evaluated a cohort of 785 children referred to our (tertiary)
hospital for suspected food allergy between 1995 and 2001. All children were
screened for food-specific sensitization by using in vitro IgE detection, and skin
prick tests. We analyzed patterns of sensitization for the three major food allergens;
cow’s milk, hen’s egg and peanut in these children. To compare the screening for
food-specific sensitization using in vitro IgE detection or skin prick testing, we
evaluated all sensitized patients for differences between outcome of both tests.
PATIENTS AND METHODS
Patients
We evaluated a cohort of 785 children referred to our pediatric allergy outpatient
clinic between September 1, 1995 and March 1, 2001. All children had been
referred for suspected food allergy based on medical history and physical
examination. Table 1 shows the indications for screening for food-specific
sensitization in children referred to our hospital. Median age was 1.6 years (range:
0-15.7). All children were screened for food-specific sensitization by using in vitro
IgE detection, and skin prick tests (SPTs). Sensitization was defined as a positive
result in either the in vitro IgE detection test, and/or the SPT.
In vitro IgE detection
Serum samples from all patients were analyzed for specific antibodies to cow’s
milk, hen’s egg, and peanut. Analyses were done with the CAP system FEIA
(Pharmacia Diagnostics, Uppsala, Sweden) in accordance with manufacturer’s
instructions. An antigen-specific IgE-value of more than 0.35kU/L was considered
as positive.
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Skin prick test
SPTs were performed using European and American recommendations12,13. Tests
were performed on the backs of infants and on the forearm of older children. Tests
were performed using a lancet technique using extracts of the relevant foods: cow’s
milk, hen’s egg, and peanut (ALK-Abelló, Nieuwegein, The Netherlands). Results
were evaluated after 15 minutes. A positive skin test was classified as a wheal of
3mm or larger. Histamine (10 mg/ml) and a diluent solution were used as positive
and negative controls respectively.
Statistical analysis
Non-Parametric analysis (Chi-square test) was applied to determine significant
differences in outcome of in vitro- and skin test results between the different age
groups. Differences associated with p values of less than 0.05 were considered
significant.
RESULTS
Patterns of sensitization for the three allergens
We investigated patterns of sensitization for cow’s milk, hen’s egg and peanut in
the 785 referred children. Sensitization was defined as a positive in vitro IgE
detection test and/or a positive SPT. Figure 1 shows percentages of sensitization in
the total study group. The most common allergen in the total group was hen’s egg,
with 51% of the referred children being sensitized. Second most common allergen
was peanut (38%) followed by cow’s milk (35%).
Table 1. Indications for screening for food-specific sensitisation
in children with suspicion of food allergic symptoms.
Skin Urticaria/angioedema
Erythematous pruritic rash
Atopic dermatitis
Respiratory tract Wheezing/repetitive cough
Nasal congestion
Pruritus/sneezing
Laryngeal oedema
Rhinorrhea
Gastrointestinal tract Abdominal cramping/colic
Vomiting or reflux
Diarrhea
Pruritus and swelling of the lips
    tongue or oral mucosa
Nausea
Cardiovascular Hypotension/shock
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To evaluate possible age-related differences in food-specific sensitization between
infants, young children and older children, three age groups were defined; 0-1
years, 1-4 years, and children older than 4 years. Figure 2 shows percentages of
sensitization in these age groups. In infants, hen’s egg was the most common
allergen (48%), followed by cow’s milk, and peanut. Hen’s egg was also the most
common allergen in young children, with a high percentage of children being
sensitized (58%). In this age group, peanut sensitization was more common than in
infancy, and was similar to cow’s milk sensitization. In the group of children who
were older than 4 years, peanut was the most important allergen, with 48% of the
referred children being sensitized. Both hen’s egg and cow’s milk sensitization was
less common than in the group of children from 1-4 years.
Mismatch between in vitro IgE detection and skin prick testing
We compared the screening for food-specific sensitization using in vitro IgE
detection or skin prick testing. Therefore, we evaluated all sensitized patients for
differences between outcome of both tests. Figure 3 shows the outcome of in vitro
testing, and skin testing, in all patients sensitized for cow’s milk (Figure 3A), hen’s
egg (Figure 3B), and peanut (Figure 3C). There was a considerable mismatch
between the outcome of both tests. For all three allergens applied that a large
proportion of the sensitized patients had a positive result for only 1 of both tests.
For cow’s milk, the proportion of sensitized patients that had only 1 positive test
was 54%. For hen’s egg this was 44%, and for peanut 45%.
To analyze the observed mismatch between in vitro testing and skin testing, we
investigated if the group with a positive result for only the in vitro test (and with
negative skin test), did not solely consist of patients with marginally elevated
allergen-specific IgE levels. This analysis showed that, for cow’s milk, 47% of the
patients in this group allergen-specific IgE levels >0.7kU/L. For hen’s egg, this
proportion was 54%, for peanut it was 65%.
Furthermore, we evaluated if the observed mismatch between in vitro and skin-
tests was different in infants compared with children older than 1 year (Figure 4).
Figure 1. Percentages of sensitization for
cow’s milk, hen’s egg, and peanut in the
total study group (n=785). Sensitization
was defined as a positive result in either
the in vitro IgE detection test, and/or the
SPT.
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Results showed, for both cow’s milk (Figure 4A) and hen’s egg (Figure 4B), that
the proportion of sensitized patients with only 1 positive test was slightly larger in
the group of children under 1 year of age, but these differences were not significant
(cow’s milk p=0.17, hen’s egg p=0.35). For peanut (Figure 4C) the proportion of
sensitized patients that had only 1 positive test was also larger in the group of
children under 1 year of age, and this difference was significant (p=0.02).
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Figure 2. Percentages of sensitization
for the three allergens in the age
groups: less than 1 yr (A), 1-4 years
(B), and older than 4 years (C).
Sensitization was defined as a positive
result in either the in vitro IgE detection
test, and/or the SPT.
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DISCUSSION
In this study we evaluated a cohort of 785 children, referred for suspected food
allergy to a tertiary hospital. We analyzed patterns of sensitization for the major
food allergens: cow’s milk, hen’s egg and peanut in these children. The incidence
of sensitization in the total study population was 35% for cow's milk, and 38% for
peanut.  The  most  common  allergen  was  hen’s  egg,  with   51%  of  the  referred
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Figure 3. Differences between
outcome of in vitro IgE test and
SPT, in all patients sensitized for
cow’s milk (A), hen’s egg (B), and
peanut (C).  IgE+ = positive in vitro
IgE-test. SPT+ = positive SPT.
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Figure 4. Differences between outcome of in vitro IgE test and SPT, in patients sensitized
for the cow’s milk (A), hen’s egg (B), and peanut (C) in two agegroups: less than 1 yr, and
older than 1 year. IgE+ = positive in vitro IgE-test. SPT+ = positive SPT. Differences
between the two agegroups are not significant for cow’s milk and hen’s egg (Chi-square test;
p=0.17 and p=0.35), and are significant for peanut (Chi-square test; p=0.02).
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children being sensitized. This percentage varied between the different age groups,
but in all children younger than 4 years of age hen's egg was the most frequent
allergen. In children older than 4 year was peanut the most frequent allergen, with
48% of the referred children being sensitized. Still, 43% of the referred children in
this age group were sensitized for hen's egg.
The results from this cohort confirm that hen’s egg is the most important food
allergen in infants and young children. In a recent study, Kulig and co-workers
studied the natural course of sensitization to food allergens in a large population-
based sample, and found that hen’s egg is the most frequent food antigen that leads
to sensitization during infancy and childhood14. Based on their cohort sample they
estimated that the prevalence of hen’s egg sensitization in an unselected population
is approximately 6% at the age of 1 year. In addition, they concluded that
sensitization to hen’s egg at the age of 12 months is the most predictive marker for
occurrence of sensitization to inhalant allergens at a later age6,14, which has been
confirmed by others15. This emphasizes that already during the first year of life,
hen’s egg is a very important allergen. Cow’s milk, being usually the first food
antigen that is introduced into an infants’ diet, is often considered as the major food
antigen in infancy. The results from our study, show however that hen’s egg
allergens should also be taken into account when an infant is evaluated for
suspicion of food allergic symptoms. Striking in this respect is, that nearly 50% of
the infants referred to our hospital had already been sensitized for hen’s egg.
To compare the screening for food-specific sensitization using in vitro IgE
detection or skin prick testing, we evaluated all sensitized patients in our study for
differences between the outcome of both tests. The results showed that, for all three
allergens, a large part (44-54%) of the sensitized patients had a positive result in
only one of both tests. The proportion of sensitized patients who had a positive
result in both the in vitro test and the skin test varied slightly between the three
allergens, but was 56% at most. This is low, and shows a substantial mismatch
between the detection of food-specific sensitization using in vitro IgE detection and
skin prick testing. IgE-mediated immune responses in infants generally are less
developed than in older children and adults10,16,17. As a large part (33%) of the
patients referred to our hospital consisted of infants, we evaluated if the observed
mismatch between in vitro and skin-testing was different in infants compared with
children older than 1 year. This analysis showed, for cow’s milk and hen’s egg, no
differences between infants and older children. For peanut, an even larger
proportion of infants had a positive result in only one of both tests compared with
older children. This indicates an even greater mismatch between both tests in this
age group.
Screening for food-specific sensitization using in vitro and/or skin tests has become
an essential step in the diagnostic work-up of children with suspected food allergy
as it provides guidance for selecting foods for DBPCFCs1,10. In several clinics,
screening for sensitization is performed using only one of both test-methods
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because of time, expense or discomfort for the patient. The results from our study
clearly show that screening using only one of both tests is insufficient. If only the
in vitro-test had been used for screening in our study group, depending on the
allergen, 17-27% of the sensitized patients would have been missed. In case the
SPT had been solely used, 23-28% of the patients would have been missed. This
means that it is imperative for pediatric clinicians to use both test-methods when
evaluating a child with suspected food allergy. Screening for food-specific
sensitization should be performed using both in vitro-IgE detection and skin testing
to prevent false-negative screening results. This applies for the total pediatric age
group, and certainly for infants.
Results of in vitro and skin-tests in this study were expressed as positive or
negative, based on standardized and generally accepted cut-off values that are
widely used12,13,18. These values determine the presence of an IgE-mediated
immune response to the food, which is not present in non-atopic individuals, and
which is therefore generally accepted to be the best reference point in the screening
for food-specific sensitisation8,10,11. Recently, it has been suggested that not just the
presence or absence of food-specific IgE antibodies, but also the level of the
specific IgE titer is associated with the risk of clinical reactivity19-21. These studies
have tried to define cut-off levels which make it possible to diagnose or exclude
clinical reactivity with greater than 95% certainty, without performing food
challenges. This same principle has also been suggested for the size of the wheal
that appears during the SPT22. The results of these studies are promising, however
further studies with large cohorts of patients are needed to standardize these cut-off
values, before they can be implemented into clinical practice.
In summary, detection of allergen-specific IgE by in vitro methods and skin prick
testing are important methods to detect sensitization for food allergens. In this
study we evaluated the screening for sensitization for the three major food
allergens; cow’s milk, hen’s egg and peanut in a large cohort of children with
suspected food allergy. The results from this study show that there is a considerable
mismatch between the outcome of in vitro IgE detection and skin prick testing
when screening for food-specific sensitization in the population of children referred
for suspected food allergy. This means that screening in the pediatric age group
should be performed using both in vitro IgE detection as well as skin prick testing,
to prevent false-negative results.
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ABSTRACT
The golden standard to diagnose clinical significant cow’s milk allergy (CMA) is
by means of a milk-provocation using a placebo-controlled protocol with blinded
patients and observers. In most pediatric settings however, provocations are usually
performed using open challenges, because this is less time-demanding and labor-
intensive. We have therefore designed a protocol for a double-blind, placebo-
controlled cow’s milk challenge (DBPCCMC) that can be used to diagnose
immediate-type allergic reactions to milk in a normal pediatric clinical setting. Our
experience with this protocol in 154 children referred to our pediatric outpatient
clinic over a two-year period, showed that it is possible to perform blinded-
challenges routinely in the diagnostic work-up of children with suspicion of CMA.
The protocol that we describe, provides a safe and efficient method to accurately
diagnose immediate-type allergic reactions in infants and children. As it is
generally accepted that DBPCCMCs are superior to open challenges because of the
significant improved value, and parental acceptance of the diagnosis, we propose
that DBPCCMCs should be implemented into routine pediatric practice, to prevent
inaccurate diagnosis and unnecessary elimination diets.
INTRODUCTION
CMA is one of the major food allergies during infancy and childhood1,2. It is
estimated that cow’s milk leads to allergic reactions in 2-3% of all infants and
children3-5. The immediate-type allergic reactions that can occur after ingestion of
milk vary from cutaneous symptoms such as urticaria and erythematous rash, to
vomiting and respiratory wheezing2.
Despite advances in the understanding of the mechanisms of CMA6, the existing
in-vitro methods for the detection of clinically significant CMA are of poor
diagnostic accuracy7,8. The only way to diagnose clinically relevant CMA is
therefore by means of a clinical provocation with cow’s milk. In most pediatric
settings, this is performed by an open feeding with milk (open challenge). It has
been shown however, that allergic reactions diagnosed during open challenges are
often difficult to reproduce with a provocation during which both patients and
observers are unaware of the challenge-content (blinded challenge)9. It is therefore
clear, that the golden standard to diagnose CMA is by means of a double-blind,
placebo-controlled milk challenge, to prevent false-positive results7,8,10.
The principles on which blinded milk challenges should be based are widely
accepted10,11, and several protocols have been described9,12-14. Performing double-
blind challenges, however, can be very time-consuming and labor-intensive, and
most described protocols are therefore limited to use in research-settings.  To
prevent inaccurate diagnosis and the costs and burden of unnecessary elimination
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diets, it is important that the diagnosis of CMA in routine practice should also be
established using double-blind challenges15.
For these reasons, we designed a protocol for a double-blind, placebo-controlled
cow’s milk challenge (DBPCCMC) that can be used to diagnose immediate-type
allergic reactions to milk routinely in an outpatient clinical setting. In this report,
we describe the protocol, and our experience with it during the diagnostic work-up
of 154 infants and children suspected of CMA in our hospital, during the period
1999-2001.
DESCRIPTION OF THE CHALLENGE-PROTOCOL
Challenge formulas
For each DBPCCMC, 2 challenge formulas were prepared. The placebo-formula
contained no cow’s milk proteins, and was based on Nutramigen (Mead Johnson,
Woerden, The Netherlands); a commercially available extensively hydrolyzed
infant formula. The content of the active-formula was constructed in a manner so
that the cow’s milk protein-content was similar to that of regular infants formula
(1,8 gr/100 ml). This was done by a mixture (ratio 11:3) of Nutramigen and
Protifar (Nutricia, Zoetermeer, The Netherlands); a cow’s milk protein-enriched
formula. Both placebo-, and active-formula were comparable with regard to aspect,
odor and taste. Food technicians prepared both formula’s, which were put in
similar bottles to assure blinding, and were subsequently randomly recoded into
‘formula A’ and ‘formula B’. 
Challenge routine
Children that underwent the DBPCCMC were admitted to the day-care ward of our
hospital. After a physical examination, the DBPCCMC was started, always with
‘formula A’. First step was application of a droplet of formula to the lips of the
child. If no reaction had occurred after 15 minutes, the challenge was continued
following a scheme with increasing amounts of formula (Table 1). If 1 hour after
the last dose no allergic reactions had occurred, the second part of the challenge
Table 1. Challenge protocol for each part of the DBPCCMC.
Step Time (minutes) Amount
1 0 droplet
2 15 10ml
3 40 20ml
4 60 30ml
5 80 40ml
6 110 60ml
7 150 90ml
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was started. This was performed with ‘formula B’, and was done using the same
scheme as with ‘formula A’. If no allergic reactions had occurred during the
challenge with both formula’s, the child was sent home at the end of the challenge
day. An open feeding with the child’s regular (cow’s milk proteins containing-)
food was started the next day.
Diagnosis of CMA
Challenges were performed while both patients and parents, as well as attending
nurses and physicians were unaware of the contents of the formula (double-
blinded). Before each part of the DBPCCMC, a routine physical examination was
done by an attending pediatrician, and results were recorded on a special challenge-
form. When symptoms of an allergic reaction occurred during the challenge, these
were investigated by the same pediatrician, and recorded at the form. If reactions
were unclear or only subjective, the last dose was repeated before the challenge
proceeded with the next step. If objective allergic symptoms occurred, and
persisted and/or deteriorated during the next step, the challenge was stopped, and
medication was given if necessary. Subsequently the code was opened, and the
diagnosis of CMA was confirmed when the symptoms had occurred during feeding
with the active-formula.
RESULTS IN 154 INFANTS AND CHILDREN WITH SUSPICION OF CMA
Description of the study-cohort
Between June 1, 1999 and March 1, 2001, 154 children underwent a DBPCCMC-
challenge to diagnose or exclude CMA. Eighty-five (55%) of these children were
boys, 69 (45%) were girls. Age varied between 0.25-14 years (median 1.5 years).
Fifty-eight (38%) were younger than 1 year of age (infants), 41 (27%) were 3 years
or older.
All children had been referred to our pediatric allergy outpatient clinic because of
symptoms suspicious for CMA, and had been on a cow’s milk-free diet
(elimination) for at least 1 month prior to challenge. Table 2 shows symptoms
and/or indications for DBPCCMC in these children. Symptoms were mostly
limited to the three following organ systems: skin, gastro-intestinal tract and the
respiratory tract. The most common complaint was atopic dermatitis, with 113
(73%) of the referred children having this symptom. Abdominal cramping and/or
colic was also very common, with 42 (27%) of the children having this symptom.
Overall, 120 children (78%) had cutaneous symptoms, 64 (42%) had symptoms in
the gastro-intestinal tract, and 30 children (19%) had respiratory symptoms.
Symptoms in multiple organ systems were reported very commonly; 61 (40%)
children had symptoms in more than 1 organ system, 3 children (2%) had
symptoms in all three tracts. The combination of skin and gastro-intestinal
Double-blind, placebo-controlled challenge
105
symptoms was the most common combination. Sixty (99%) of the patients that had
symptoms in more than 1 organ-system did have skin symptoms. Three children
that were referred for DBPCCMC had been on a cow’s milk-free diet (elimination)
since birth, because of a positive family history of CMA. These patients had never
encountered cow’s milk prior to the challenge.
Outcome of DBPCCMCs
In 133 of the 154 children that were tested, the diagnosis of CMA was rejected
because no objective symptoms of allergy occurred during DBPCCMC. Although
subjective symptoms, such as mild gastro-intestinal distress or irritability, were
reported by some patients during the test, these symptoms invariably disappeared
during the next steps in the challenge, with increasing amounts of formula. All 133
children completed the complete challenge protocol without objective allergic
symptoms, and cow’s milk could be re-introduced into the diet at home in all 133
children, without the occurrence of immediate-type allergic reactions. No reactions
to placebo were seen in this group.
Symptoms during DBPCCMC in the CMA-patients
The DBPCCMC showed a positive result in 21 (14%) of the referred children.
These children were diagnosed with CMA. Age of CMA-patients varied between
0.25-14 years (median 1.3 years). Eight (38%) were less than 1 year of age, 7
(33%) were 3 years or older. The symptoms that occurred during the challenge in
the patients that were diagnosed with CMA varied, but mostly showed a similar
pattern. In 5 of the 21 CMA-patients (24%), application of a droplet of cow’s milk
at the lip already resulted in urticarial reactions and/or erythema around the mouth
Table 2. Referral-indication for DBPCCMC in the total study group.
Organ Symptom No*
Skin Urticaria/angioedema 13
Erythematous pruritic rash 7
Atopic dermatitis 113
Respiratory tract Wheezing/repetitive cough 29
Nasal congestion 2
Pruritus/sneezing 1
Laryngeal oedema 1
Gastrointestinal tract Abdominal cramping/colic 42
Vomiting or reflux 22
Diarrhea 7
Other Failure to thrive 1
Positive family history for CMA 3
* number of children with this symptom
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and in the face. In 1 of these infants, this was accompanied by symptoms of
angioedema and inspiratory stridor, at which point the challenge was stopped. In
the other 4, the symptoms of erythema returned and progressed during the next 3
steps in the challenge procedure (10-30ml). Eight of the 16 CMA-patients who did
not react to the application of a droplet of cow’s milk to the lips, developed the first
symptoms of an allergic reaction during the next 3 steps in the challenge procedure
(10-30ml). The symptoms in these patients were urticaria and/or erythema of the
skin. This was mostly present around the mouth and in the face. One of these
patients reported severe abdominal cramping. The symptoms in these patients
aggravated during the increase of the milk-intake, upon which the test was
discontinued. Of the 8 patients who developed the first allergic symptoms during
the later stage of the DBPCCMC (40-90ml), 6 had skin symptoms. This concerned
urticaria and/or erythema of the skin, mostly in the face. One of these patients had
accompanying pulmonary problems, i.e. wheezing and inspiratory stridor. The two
patients who did not have skin symptoms, reacted to cow’s milk ingestion with
vomiting. One of these also experienced severe abdominal cramping.
Taken together, 19 (90%) of the CMA-patients had cutaneous symptoms at one or
more points during the DBPCCMC. In 2 of these patients this was accompanied by
respiratory symptoms, in 1 by gastro-intestinal problems. Two CMA-patients
(10%) did have isolated gastro-intestinal symptoms (vomiting). No reactions to
placebo were seen in the CMA-patients.
Results of screening for cow’s milk-specific sensitization in CMA-patients
Most of the children that were referred for DBPCCMC had been tested for cow’s
milk-specific sensitization prior to the DBPCCMC. This was done by using IgE-
detection with the CAP system FEIA (Pharmacia Diagnostics, Uppsala, Sweden),
and/or skin testing using the skin prick test (SPT)16,17. Results were available for 20
of the 21 CMA-patients. Of these, 18 (90%) were sensitized for cow’s milk, as
determined by a positive result in IgE-detection and/or SPT. In 2 CMA-patients,
sensitization had not been proven, but screening had only been performed using
SPT. These patients were both less than 6 months of age at the time of challenge.
The patient in which no screening had been performed prior to DBPCCMC was 6
months old at the time of challenge.
DISCUSSION
The golden standard to diagnose clinical significant allergic reactions to cow’s
milk is by means of a provocation using a placebo-controlled protocol with blinded
patients and observers8,10. However, in routine pediatric settings, milk-provocation
is usually performed by open challenge, because this is less time-demanding and
labor-intensive. We designed a protocol for a DBPCCMC that can be used to
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diagnose immediate-type allergic reactions to milk in a routine pediatric clinical
setting. The protocol was tested in a cohort of children (n=154) that were referred
for milk-challenge over a two-year period in our hospital. A diagnosis of
immediate-type CMA was established in 21 children (14%), and could be excluded
in 133 (86%). There was a good correlation between the symptoms that were
reported during previous ingestion of milk and outcome of DBPCCMC in the
CMA-patients. The challenge-formula’s that were used, were acceptable for
children of all ages, including infants and pre-adolescent children, showing that
this protocol can be used to diagnose immediate type reactions to cow’s milk in
virtually every child with suspicion of CMA.
The described protocol provides for a safe way of challenging children at risk for
allergic reactions, by starting with small dosages of challenge-formula. In children
that were considered to be at high-risk for allergic reactions, we usually prepared
an IV-line for precautionary measures. None of the tested children experienced
life-threatening allergic reactions that required additional hospitalization.
Furthermore, we wanted to prevent false-negative challenges that could lead to
anaphylactic reactions during the re-introduction of milk at home. Studies from
literature have suggested that immediate-type allergic reactions can be ruled out
when an individual has ingested up to 10 gr of dehydrated food without
problems8,18. As dehydrated milk consists for approximately a third of proteins19,
this would suggest a ‘secure dose’ of 3.3 gr milk proteins. The challenge-formulas
were therefore constructed so that children who completed the entire protocol had
ingested at least 4.5 gr of pure milk proteins. As a result, all immediate-type
reactions that occurred in our cohort, occurred during the hospital-admission, and
none of the 133 children with a negative challenge-result experienced immediate-
type reactions at home during re-introduction of milk. This shows that the
described protocol provides a safe procedure to reproduce allergic symptoms, and
prevents unwanted false-negative results.
It is generally accepted that double-blind, placebo-controlled challenges are
superior to open challenges because of the significant improved diagnostic
value8,10,11. Moreover, studies have shown that the parental acceptance of a
diagnosis of CMA based on DBPCCMC, is much higher than a diagnosis that has
been established during open challenge9. This is important, as it may drastically
improve adherence to the assigned elimination diet. For these reasons, we propose
that double-blind, placebo-controlled milk challenges should be implemented into
routine pediatric practice, to improve accurate diagnosis in infants and children
with suspicion of CMA. Results from our two-year experience show that the
hereby-presented protocol is a safe and efficient method to diagnose immediate-
type reactions in infants and children, and can be used routinely in a pediatric
outpatient clinic. Usage of this protocol instead of open challenges may reduce
false-positive diagnosis and unnecessary elimination diets.
Most of the children that were referred for DBPCCMC in our study-cohort had
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been screened for cow’s milk-specific sensitization by using in vitro IgE-detection
and/or SPT. Results showed that all but three patients that were diagnosed with
CMA during DBPCCMC were sensitized for cow’s milk. This supports the current
hypothesis that cow’s milk-specific sensitization, i.e. the presence of an IgE-
mediated immune reaction to milk, is important in the aetiology of immediate-type
reactions2,6. In the three patients in whom cow’s milk-specific sensitization was not
established, screening had only been performed using the SPT. We recently
evaluated the screening for food-specific sensitization in a large group of patients
with suspicion of food allergy (n=785), and noted a significant mismatch between
results of in vitro IgE detection and skin prick testing, especially in infants20. This
means that we cannot exclude sensitization to cow’s milk in these 3 patients, who
were all younger than 7 months of age. Overall, in our study, none of the children
that were older than 1 year of age and were not sensitized for cow’s milk, showed
immediate-type reactions during DBPCCMC. It is therefore tempting to speculate
that patients who are not sensitized, and who are older than 1 year of age, do never
experience immediate-type reactions to cow’s milk. This means that these patients
do not have to be challenged, which would drastically reduce the need for
challenges in a routine pediatric setting. This principle has also been suggested by
Sampson and co-workers, who suggested from a statistical model that patients with
cow’s milk-specific IgE levels of less than 0.8 kU/L, have a predictive value for a
negative outcome of the DBPCCMC of more than 95%21,22. These observations
have been done in a relatively small number of patients, and have therefore to be
extended to larger groups before they can be applied in routine pediatric practice.
The protocol that we present in this report is designed to diagnose ‘classical’,
immediate-type allergic reactions to cow’s milk. It has been suggested that patients
with CMA can also have isolated ‘late’ or ‘delayed-type’ reactions2. These are
allergic reactions who are said to arise only after more than 24 hours intake of
cow’s milk13,14. This does not concern acute, life-threatening symptoms, but
comprises a negative influence of milk-ingestion on chronic conditions such as
infantile colic or atopic dermatitis, in the absence of acute reactions. To prove these
reactions using DBPCCMC is difficult, as it requires a prolonged double-blind,
controlled administration of cow’s milk proteins or placebo in high doses,
corresponding to normal daily intake23. We have recently performed a pilot-study
with a protocol for a prolonged-DBPCCMC, in which infants with suspicion of
delayed-type reactions to cow’s milk were given blinded test-formulas for 2x1
weeks (unpublished data). Both test-formulas contained normal amounts of
proteins, but only the active-formula contained intact proteins from cow’s milk.
Results showed that it is possible to perform these kind of prolonged challenges in
a double-blind manner at home. However, as these challenges are very labor-
intensive, they should be reserved for research-settings, or for special cases, in
which routine diagnostics fails to establish an unequivocal diagnosis of delayed-
type CMA.
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In summary, we show that it is possible to perform double-blind, placebo-
controlled milk challenges routinely in infants and children that are referred to a
pediatric outpatient clinic. The protocol that is presented here provides a safe and
efficient method to diagnose immediate-type allergic reactions to cow’s milk in a
double-blind manner. Implementation of this protocol into routine pediatric
practice can reduce inaccurate diagnosis and the costs and burden of unnecessary
elimination diets.
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INTRODUCTION
Cow’s milk allergy (CMA) is one of the major allergies during early childhood,
and is usually the first presentation of the atopic state of an individual. Unlike other
(food) allergies, CMA in infancy is associated with rapid and spontaneous
development of clinical tolerance. Elucidation of the mechanisms that determine
the development of allergy and tolerance to cow’s milk, may not only provide
insights for therapeutic strategies for CMA, but also other (food) allergies. The
studies presented in this thesis investigate the role of cow’s milk protein (CMP)-
specific T cells. In this chapter, findings on the relevance of circulating CMP-
specific T cells in the aetiology of CMA are summarized and discussed. A model is
presented (Figure 1) which describes the development of the CMP-specific T cell
response in blood of atopic and non-atopic individuals during infancy and early
childhood.
THE RELEVANCE OF CMP-SPECIFIC T CELL REACTIVITY IN THE
AETIOLOGY OF CMA
In this thesis, it was shown that CMP-specific T cell reactivity can be demonstrated
in blood of infants with CMA and AD, but also in infants with AD without CMA
(Chapter 2 to 5). This clearly shows that the presence of a CMP-specific T cell
response per se, does not determine CMA. T cells, specific for the proteins in milk,
were also demonstrated in blood of non-atopic infants (Chapter 3, 5), which shows
that this conclusion can be extrapolated to individuals without atopy. The presence
of CMP-specific T cell reactivity in blood of young children that had outgrown
their CMA (Chapter 4, 5), further emphasizes that CMA is not caused by a CMP-
specific T cell response per se.
Cow’s milk consists of several different protein-fractions that may provoke an
immune reaction in man, the most important being the whey and casein proteins1-3.
From investigations at the humoral level (IgE), it is known that no particular
protein-fraction in milk accounts for the allergenicity of cow’s milk4-7. In this
thesis, it was shown that T cells specific for both protein-fractions are present in
blood of infants with and without CMA, irrespective of their atopic state (Chapter 2
to 4). This demonstrates that, both at the humoral and at the T cell level, there is no
immuno-dominant protein-fraction in cow’s milk. Intact milk-proteins consist of
multiple joined aminoacids8, sometimes up to 200, while T cells, as well as IgE-
antibodies, recognize only small parts of the proteins (epitopes), consisting of
several aminoacids9-11. Investigations into IgE-binding epitopes have shown that
patients with and without CMA do differ in their epitope-recognition of the various
CMPs12,13. This might suggest that also for T cell epitopes, differences exist
between patients and controls, which would lead to different T cell responses
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towards the various CMPs. In this thesis, no epitope-analysis was performed,
therefore these findings cannot be verified for T cell-binding epitopes.
From investigations14-16 in patients with allergy to inhalation-allergens it is known
that circulating Th2 cells are important in the initiation of allergic tissue-
inflammation, through stimulation of IgE synthesis and eosinophil recruitment17-20.
The investigations in this thesis demonstrate that also in infants with allergy to
cow’s milk, cytokine release by the circulating CMP-specific, i.e. disease-relevant,
T cells is Th2-biased, in contrast to infants without CMA (Chapter 2, 3). This had
already been suggested by previous studies with PBMCs21-23, but is confirmed at
the clonal level in this thesis. The Th2-biased nature is demonstrated by the
production of IL-4, the hallmark cytokine of the Th2-response, which is higher in
infants with CMA compared to (age-matched) atopic, and non-atopic infants
without CMA (Chapter 2, 3). This Th2-skewing of the CMP-specific T cell
response is further reflected by high release of IL-5 and IL-13, two cytokines that
are also closely associated with release of IL-4 (Chapter 2, 3).
In combination with this Th2-biased cytokine pattern, the activation state of
antigen-specific T cells is probably also of importance in the aetiology of allergic
reactions to CMPs. Analysis of the cell surface expression of CD25 (IL-2Rα), the
high affinity receptor for IL-224 showed that the expression of this activation-
marker by CMP-specific T cells of infants with CMA is significantly higher than in
atopic and non-atopic infants without CMA (Chapter 5). Similar results were found
for cell surface expression of CD30, another marker of T cell activation25, which is
closely associated with CD25 expression (Chapter 5). Investigations in PBMCs
showed that CMP-specific T cells from patients with CMA in vitro generally have
a higher proliferative capacity than T cells from individuals without CMA26-35. The
studies in this thesis suggest at the clonal level that CMP-specific T cells from
patients with CMA have an enhanced activated phenotype. These findings may
indicate that the in vivo CMP-specific T cell response in patients with CMA is by
itself more vigorous. In line with this hypothesis, it was demonstrated in this thesis
that the development of clinical tolerance for CMA is associated with a
downregulation of the CMP-specific (Th2) response. Both Th2-cytokine
production (Chapter 4), and activation level (Chapter 5) of the circulating CMP-
specific T cells is lower after the development of tolerance for CMPs. This
indicates that certain, currently unknown, mechanisms cause a change in the CMP-
specific T cell response, resulting in a clinical CMP-tolerant state of a patient with
CMA.
Interestingly, in this thesis, differences between patients with and without atopy
were found with respect to T cell expression of CD26 (the receptor for adenosine
deaminase) and CD30. It was shown that the expression of CD26 by CMP-specific
T cells from atopic individuals is higher, and the expression of CD30 is lower than
in individuals without atopy (Chapter 5). The exact functions of CD26 and CD30
remain unknown36-39, but these findings suggest that the expression of these
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markers by T cells is a reflection of the atopic state of a patient. The previously
suggested40-42 association between the cell-surface expression of both markers and
the production of Th1 and Th2 cytokines by CMP-specific T cells was also
investigated (Chapter 5). This confirmed earlier studies which demonstrated that on
the level of the individual T cell, CD26 and CD30 cannot be used as exclusive
markers for Th2- and Th1-cells43-45.
This thesis focused on infants with CMP-induced allergic inflammation in the skin.
The expression of cutaneous lymphocyte antigen (CLA), a cell surface protein, is
proposed to play a key role in the skin-infiltrating capacity of circulating antigen-
specific T cells46-48. Analysis of the expression of CLA by the CMP-specific T cells
in blood of patients with CM-induced skin symptoms showed that CLA-expression
is comparable to T cells from individuals without allergic skin disease (Chapter 6).
This suggests that the skin-homing potential of these T cells is not intrinsically
different, but that other factors49, perhaps in combination with the cytokine pattern
and activation state of the T cell, determines migration to the skin, and the
development of an allergic skin reaction.
THE DEVELOPMENT OF THE CMP-SPECIFIC T CELL RESPONSE
DURING INFANCY AND EARLY CHILDHOOD
The T cell response in individuals without an atopic predisposition
Proliferative responses to the proteins in cow’s milk have been shown in cord
blood of atopic and non-atopic individuals50-60. This means that already at birth
CMP-specific T cells are present in blood of atopic and non-atopic individuals.
Priming of T cells against CMP-proteins thus may occur in utero, through
mechanisms which are currently unknown61-63. Recent studies by Prescott and co-
workers showed that the allergen-specific T cell response to foods in both atopic
and non-atopic individuals is Th2-skewed at birth58,59,64. This is probably secondary
to the fact that T cell responses in all individuals are Th2-skewed in utero, to
prevent the toxic effects of the Th1-cytokines on the placenta and the ‘allogenic’
fetus65,66. Postnatally however, the development of T cell responses to
environmental allergens in individuals with or without an atopic predisposition is
essentially different59,62,64. It was suggested that in non-atopic individuals these
Th2-responses are gradually suppressed, to prevent sensitization to environmental
allergens64. Results presented in this thesis demonstrated that the T cell response to
cow’s milk in non-atopic individuals is indeed associated with a low production of
the Th2-cytokines (Chapter 3). This indicates that allergy to CMPs in these
individuals is successfully prevented by a downregulation of the fetal Th2-
response.
Investigations in PBMCs have suggested that antigen-specific T cell responses
generally deviate to a Th1-biased pattern in individuals without an atopic
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predisposition62,64. However, the studies in this thesis show that, when investigated
at the single cell level, the T cell response to milk in non-atopic infants displays a
balanced, Th0-like cytokine profile, with equal production of IL-4 and IFN-γ
(Chapter 3). As the strong inflammatory capacities of Th1-cytokines, such as IFN-
γ, can be harmful, it seems logical that a balanced (i.e. Th0-like) cytokine response
to environmental allergens is better than a full-blown Th1-response that is
dominated by IFN-γ release. Therefore, it is likely that the T cell response to milk
in non-atopics remains Th0-like throughout life, although this has yet to await
formal prove. Studies have shown proliferative responses to cow‘s milk in PBMCs
of non-atopic adults34,67 which demonstrates the persistence of a CMP-specific T
cell response in blood of non-atopics into adulthood. Cytokine release by these
CMP-specific T cells however has not been investigated at the single cell level so
far.
Figure 1.  Model that describes the development of the CMP-specific T cell response in
non-atopic and atopic individuals. Results from birth are extrapolated from data in
references 58 and 64. Results from infancy and early childhood are described in this thesis
(Chapter 2-5).  Results from late childhood are extrapolations of results described in this
thesis (Chapter 2-5).
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The T cell response in atopic patients with CMA
Studies that investigated the postnatal development of allergen-specific T cell
responses concluded that, in contrast to individuals without atopy, the fetal
allergen-specific (Th2) responses in individuals with an atopic predisposition
remain Th2-skewed during infancy and childhood59,60,64. However, these studies
made no distinction between the allergen-specific T cell response in atopic patients
with, and without allergic reactions to that specific allergen. In this thesis, it was
demonstrated at the clonal level, that atopic infants with allergy to CMPs have a
Th2-biased, CMP-specific T cell cytokine response in blood (Chapter 2). This T
cell response, with high levels of IL-4, IL-5 and IL-13, most probably mediates
allergic tissue inflammation similar to the mechanisms that have been shown for
allergic reactions to inhalants17,19,20. The finding that CMA in infancy is associated
with a Th2-biased T cell response, may indeed indicate that CMA is the result of a
temporary delay in the (normal) redirection of the fetal Th2 response. The fact that
CMA in infancy is remarkably transient, i.e. most patients become spontaneously
tolerant to milk within 2 years68,69, supports this hypothesis.
Investigations in this thesis showed that this spontaneous development of clinical
tolerance to milk in infants with CMA is associated with a downregulation of Th2-
cytokine release, while at the same time IFN-γ production is up-regulated (Chapter
4). This results in a deviation of the CMP-specific T cell cytokine response towards
a Th1-type profile. It is tempting to speculate that in infants that have developed
allergy to milk, an ‘overshoot’ deviation of the (Th2-biased) CMP-specific T cell
response to a Th1-profile, is needed to induce the CMP-tolerant state in these
patients. The CMP-specific T cells still show an enhanced activated state at this
timepoint, as reflected by the higher cell surface expression of CD25 than control
patients (Chapter 5). These findings suggest that the increased Th1-cytokine
release, in combination with the enhanced activated phenotype is needed for the
maintenance of the CMP-tolerant state in these patients. It is likely that, in due
time, this CMP-specific Th1-biased T cell response will be downregulated to a
balanced, Th0-like response. As argued before, a full-blown Th1-response with
high levels of IFN-γ may have harmful effects. Therefore, it is plausible that with
increasing age, patients that have become clinically tolerant to milk after ‘transient’
CMA will obtain a T cell response that is comparable with atopic and non-atopic
individuals who never had CMA.
The T cell response in atopic individuals without CMA
To investigate the CMP-specific T cell response in individuals with an atopic
predisposition, but who do not have allergy to cow’s milk, infants with AD without
CMA were investigated in this thesis. These patients had existing atopic disease,
both immunologically and clinically, but they were not allergic to cow’s milk as
proven by formal challenge. In accordance with the hypothesis that production of
high levels of Th2 cytokines by allergen-specific T cells is important in the
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aetiology of allergy, it was found that CMP-specific T cells from these infants
show a low production of the Th2 cytokines (Chapter 2). Of interest however, is
the finding that the majority of these infants have CMP-specific T cells that display
a Th1-phenotype. This is in contrast with the findings from previous studies who
suggested that atopic individuals have a prolonged period of fetal Th2-skewed
allergen-specific T cell responses59,60,64. However, these studies did not
discriminate between T cell responses in atopic patients with, and without allergic
reactions to the studied allergen.
The finding that, when investigated at the single cell level, CMP-specific T cells
from atopic individuals who do not have CMA display a Th1-phenotype, raises
important questions. The hallmark characteristic of individuals with an atopic
predisposition is their tendency to develop sensitization and allergy to common
allergens. The fact that these patients had not developed CMA means that, despite
their atopic state, allergy to cow’s milk has somehow been successfully prevented.
It is tempting to speculate that the Th1–biased nature of the cytokine response is of
importance in this respect. Atopic individuals have an increased risk of developing
allergic sensitization during the first year of life, the so-called ‘window of
sensitization’64,70,71. Usually CMPs are often encountered in large quantities during
infancy. It can be argued that during this period, with its lingering fetal T cell
responses which cause a Th2-biased milieu in blood, the T cell response to milk is
more Th1-skewed in these patients to prevent sensitization. The finding that the
Th1-skewed cytokine response that is present in the first year of life, changes into a
Th0-like cytokine pattern after infancy (Chapter 4), is in accordance with this
hypothesis.  Most probably, after infancy, when the ‘window of sensitization’ has
passed and allergy to milk has been successfully prevented, there is no longer need
for a ‘compensatory’, Th1-biased T cell response. To prevent the potential harmful
effects of a full blown Th1-response upon exposure to cow’s milk, the response is
downregulated to a balanced, Th0-like response.
REGULATION OF THE CMP-SPECIFIC T CELL RESPONSE
The results presented in this thesis show differences in the postnatal development
of the T cell response to cow’s milk, between individuals with and without an
atopic predisposition. More importantly, differences in the development of the T
cell response between atopic individuals who did or did not develop CMA were
demonstrated. This finding, in combination with the fact that the spontaneous
development of clinical tolerance is apparently associated with a modulation of the
CMP-specific T cell response, shows that understanding of the regulatory
mechanisms that define T cell responses is of importance for the development of
therapy for CMA.
Several observations indicate that the antigen-presenting cell (APC)-apparatus is
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probably crucial in the orchestration of T cell responses. It has been shown that the
signals that APCs in the central lymphoid organs provide during the priming of T
cell responses in the perinatal period, can determine the outcome of the Th1- or
Th2-biased nature of the T cell response72,73. Work by Kalinski and co-workers
showed that distinct subsets of dendritic cells (DCs) exist, that are responsible for
primary polarization of naive T cells in the lymph nodes73,74. These DC-subsets
provide stimulatory signals during antigen-presentation that determine if the T cell
cytokine profile becomes Th1- or Th2-biased74,75. Although the exact signals
remain to be elucidated, both soluble factors such as IL-12, as well as cell-surface
interactions are probably of importance in this process73,75.
During the postnatal development of allergen-specific T cell responses, the
peripheral APC-network is proposed to play a crucial role64,71,76. It has been
demonstrated that the DC-network in the lung can orchestrate the postnatal T cell
response towards inhalation allergens77-80. The mechanisms that regulate the
postnatal immune-response to foods are less clarified, but are under investigation81.
It is clear that antigen-presenting cells in the gut-associated lymphoid tissue are of
vital importance in the induction of oral tolerance82-84. However, both the nature of
the relevant APCs, and the exact processing events are currently unclear83,84.
Furthermore, the possible role of IL-10 in the regulation of CMP-specific T cell
responses should be discussed. In adults with established allergy to birch-pollen
and bee venom, tolerance can be artificially established via allergen-specific
immunotherapy. This induces a deviation of the allergen-specific T cell response
from a Th2-response to a Th1-skewed response85-88. In this thesis, it was shown
that the spontaneous development of tolerance for CMPs is associated with a
similar Th2-Th1 switch (Chapter 4). In immunotherapy, an increase in production
of IL-10 by allergen-stimulated PBMCs can be found87,89. This cytokine is
predominantly being produced by antigen-presenting cells such as B cells and
monocytes90,91. It is thought that IL-10 is important for the modulation of the T cell
response through inhibition of proliferative responses and cytokine production91-93.
In this thesis, no evidence was found that the spontaneous development of
tolerance to CMPs is associated with an increased production of IL-10 by the
CMP-specific T cells in blood (Chapter 4). The antigen-presenting cell apparatus
however, was not investigated in this thesis. Therefore, the exact role of IL-10 in
the regulation of the CMP-specific T cell response remains to be clarified. It might
be that, similar to (artificially) induced tolerance, IL-10 production by antigen-
presenting cells plays an important role in the development of spontaneous
tolerance to cow’s milk. Future studies should therefore focus on the role of the
antigen-presenting cell apparatus, and its IL-10 production, in the regulation of the
CMP-specific T cell response.
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DIRECTIONS FOR FUTURE STUDIES
Extension of current observations to adults and patients with persistent CMA
The studies in this thesis have elucidated the nature of the CMP-specific T cell
response in atopic and non-atopic individuals in infancy and childhood. Future
studies should be focused on the extension of the observations that were made in
this thesis. Long-term follow-up of T cell responses in the patients that have
become tolerant after CMA is needed, to see if the spontaneous acquisition of
clinical tolerance is associated with a life-long, Th1-biased T cell response to
cow’s milk, or indeed develops into a downregulated, Th0-response. In addition,
the CMP-specific T cell response in atopic and non-atopic adults who never had
CMA, should be analyzed for cytokine production, to verify the hypotheses that
were made in this thesis.
CMA in infancy is a transient disease that usually disappears during early
childhood69,94. However, in a small proportion of patients, clinical tolerance does
not develop during childhood, causing ‘persistent CMA’. It is important to
investigate if the CMP-specific T cell response in these patients is intrinsically
different from the T cell response in ‘common’ (i.e. transient) CMA. The studies in
this thesis suggested that ‘common’ CMA is a temporary error in the normal
redirection of the fetal Th2-response. For unknown reasons, this redirection fails
completely in certain patients, leading tot persistent CMA. The mechanisms that
determine the development of clinical tolerance to milk in patients with transient
CMA, and the reasons why this fails, or only develops after several years in
patients with persistent CMA, need to be clarified.
The fate of T cells after the development of clinical tolerance
This thesis showed that the development of clinical tolerance to cow’s milk in
patients with CMA is associated with significant changes in the CMP-specific T
cell response. This suggests that certain, currently unknown, mechanisms modulate
the reactivity and cytokine release of the CMP-specific T cells. It is unclear
however, whether the CMP-specific T cells that were demonstrated at both
timepoints, are essentially the same T cells. One could also speculate that, in order
to acquire clinical tolerance to milk, the highly-activated CMP-specific Th2-cells
are deleted from the T cell repertoire, or become anergized. This implies that
newly-formed CMP-specific T cells, exhibiting a Th1-phenotype, shift the balance
towards a clinical tolerant response. At the moment it is unknown, which
mechanism is responsible for the observed changes in the CMP-specific T cell
response. Future research should set out to solve this question. Studies by Van
Reijsen and co-workers showed that it is possible to use the T cell receptor as a
‘fingerprint’ to trace identify identical T cell clones95,96. The exact DNA-sequence
of the variable part of the β-chain of the T cell receptor, which is unique for each T
cell, was used as a identification marker for that specific TCC. Using probes with a
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similar sequence they showed that it is possible to trace T cells in polyclonal T cell
cultures obtained from the same patient at different timepoints over a period of
several years95,96. This approach may provide insight into the mechanisms that
determine the fate of T cells after the development of clinical tolerance to cow’s
milk.
The role of circulating T cells in the aetiology of CMP-induced skin
inflammation
The findings in this thesis show significant differences in the CMP-specific T cell
response in blood of patients with CMA and AD compared to infants without
CMA, especially with regard to the production of Th2 cytokines. From
investigations in patients with inhalation-allergy, it was suggested that skin-
infiltrating, allergen-specific Th2-cells in blood are crucial in the initiation of the
allergic skin inflammation17,97,98. The skin compartment in patients with CMP-
induced skin symptoms however has not yet been investigated. Extrapolation of
reactivity and cytokine release of circulating CMP-specific T cells to mechanisms
in the skin remains therefore hypothetical. Future studies should investigate the
presence and phenotype of CMP-specific T cells in skin of CMP-allergic
individuals to elucidate the mechanisms of CMP-induced skin inflammation.
The expression of CLA is proposed to play a key role in the skin-infiltrating
capacity of a T cell46,48,99. Results from this thesis suggested that the expression of
CLA by CMP-specific T cells in blood of patients with CM-induced skin
inflammation is not essentially different from individuals without allergic skin
disease. Interestingly however, it was found that the level of CLA-expression by T
cells in blood is significantly lower than CLA-expression by skin T cells (Chapter
6). These findings imply that the level of CLA-expression, rather than the
expression per se, determines the (skin-) localization of allergen-specific T cells.
Future research into the mechanisms by which CMP-specific T cells in blood are
connected to allergic skin inflammation, should therefore include the regulation of
the level of CLA-expression by allergen-specific T cells.
Clinical manifestations of CMA
Besides the efforts to unravel the aetiology of CMA and CMP-induced skin
symptoms, future studies should focus on the improvement of the clinical
characterization of patients with CMA. The studies in this thesis have focused on
patients with immediate-type reactions to cow’s milk. It has been shown that there
are also patients with CMA who experience isolated ‘late’ or ‘delayed-type’
reactions100,101. These are allergic reactions who arise only after prolonged intake of
cow‘s milk, and are not life-threatening. It has even been suggested that patients
with CMA can be subdivided into 3 different ‘disease-profiles’. Hill and co-
workers showed that besides the immediate-type reactors, there are CMA-patients
who experience isolated gastro-intestinal symptoms, 1-20 hours after milk
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ingestion (intermediate reactors)101,102. Furthermore, they suggested that there is a
(late-reacting) subgroup of patients with AD, who show deterioration of their AD,
24 hours after milk-ingestion, in the absence of immediate-type reactions101,102. The
existence of these subgroups of CMA patients, however, has not yet been
indisputably demonstrated in double-blind test-settings that controlled for other,
disturbing factors. To prove delayed-type reactions using double-blinded
challenges, a prolonged, controlled administration of CMPs or placebo in high
doses, corresponding to normal daily intake, is required. Results from a pilot-study
that was mentioned in Chapter 8, showed that it is possible to perform these kind of
prolonged challenges in a double-blinded manner at home. Exact knowledge of the
heterogeneity of symptoms that patients with CMA may experience, and the
changes in ‘disease-patterns’ that may occur with increasing age103, is essential for
future research into CMA.
CONCLUSION
In this thesis, the role of antigen-specific T cells in the aetiology of CMA and AD
was investigated. Distinct differences between T cells in blood of infants with and
without CMA were found, especially with regard to reactivity and cytokine-release.
These differences were reflected by the change in the CMP-specific T cell response
that was observed during the spontaneous remission of CMA in patients with
CMP-induced skin disease. The presented findings strongly suggest that the nature
of the CMP-specific T cell response in blood determines the outcome of allergy
and tolerance to cow’s milk.
Furthermore, the investigations confirmed that differences exist between the CMP-
specific T cell response in atopic and non-atopic individuals during infancy and
early childhood. This suggests that the mechanisms that regulate the T cell
response to milk are of vital importance in the development of clinical tolerance to
CMPs. Future studies should therefore be focused on the elucidation of these
mechanisms, to give directions for the development of therapeutic and preventive
strategies in allergy to cow’s milk.
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SUMMARY
Allergy is an important disease that affects a substantial proportion of the general
population, and which has seen an increasing incidence during the past three
decades. Cow’s milk allergy (CMA) is one of the major food-allergies during
infancy and early childhood. This thesis focuses on patients with CMA and atopic
dermatitis (AD), which is the major presentation of CMA in the majority of
patients during childhood. The aim of this thesis is to investigate the role of
antigen-specific T cells in the etiology of CMA and AD. In addition, the currently
used methods to diagnose CMA, in vivo and in vitro, are evaluated.
In Chapter 1, a general introduction to CMA and AD in infancy and childhood is
given. CMA plays a pathogenic role in approximately a third of the infants with
AD in the first year of life, and is associated with the spontaneous development of
clinical tolerance within a relatively short period of two to three years. Similar to
inhalant-allergy, in which Th2 cells that secrete high levels of interleukin (IL)-4,
IL-5 and IL-13 are important, T cell reactivity towards the proteins in cow's milk
has been implicated in the aetiology of allergy to cow's milk. This has however not
been thoroughly investigated so far.
Chapter 2 describes differences in the cow’s milk protein (CMP)-specific T cell
response between blood of infants with AD with and without CMA. Using an
antigen-specific T cell culturing system with autologous B cells as antigen-
presenting cells, CMP-specific T cell clones were established from blood. Results
show that T cells specific for the various proteins in milk are present in blood of
infants with AD, irrespective of their atopic state. Analysis of cytokine release
shows that the CMP-specific T cell response in infants with CMA is Th2-skewed,
with production of high levels of IL-4, IL-5 and IL-13. In contrast, infants without
CMA have a Th1-skewed response, with high levels of interferon (IFN)-γ and low
levels of the Th2-cytokines.
In Chapter 3, infants without an atopic predisposition and without allergic disease
are investigated. Results show that in these individuals, a T helper cell response
directed against the major proteins in milk is evident. These T cells show a
balanced, Th0-like cytokine production with an equal production of IL-4 and IFN-
γ. Comparison of these T cells with those described in Chapter 2 emphasizes the
Th0-like phenotype of cells, and the low release of Th2 cytokines. This suggests
that similarly to individuals with an atopic predisposition, tolerance to milk in
normal individuals is not caused by absence of circulating, CMP-specific T cells,
but is probably determined by low release of Th2-cytokines by these cells.
Chapter 4 investigates the changes that occur in the CMP-specific T cell response
during the spontaneous development of clinical tolerance for cow’s milk in infants
with CMA and AD. Results show that CMP-specific T cells are still present in
blood of CMA patients that have become clinically tolerant for CMPs. However,
production of the Th2 cytokines by these T cells is lower than during the allergic
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state. In contrast, production of IFN-γ is increased, which results in a Th1-skewed
cytokine pattern. These results emphasize the important role of antigen-specific
Th2 cytokine-release in the development of allergic reactions to CMPs.
In Chapter 5, the expression of several cell-surface markers by CMP-specific T
cells is investigated. Results show that the expression of the activation markers
CD25 and CD30 by CMP-specific T cells is significantly higher in infants with
CMA, which suggest a higher activation state of these T cells. After the
development of clinical tolerance for CMPs, cell-surface expression of activation
markers decreases, suggesting a downregulation of CMP-specific T cell reactivity.
Comparison of the expression of CD26 and CD30 with the release of IL-4 and
IFN-γ confirms earlier studies which demonstrated that on the level of the
individual T cell, CD26 and CD30 cannot be used as exclusive markers for Th2-
and Th1-cells.
In Chapter 6, CMP-specific T cells from blood and skin are investigated, and
compared with regard to cell-surface expression of the skin-specific homing
marker; cutaneous lymphocyte antigen (CLA). Results show that expression of
CLA by CMP-specific T cells in patients with CMA and AD is comparable with
patients without CMA. This suggests that the skin-homing potential of T cells from
allergic and non-allergic individuals is not essentially different. Analysis of CLA-
expression by T cells in skin of patients with AD however, shows significant
higher expression levels of CLA on skin T cells compared to T cells from blood.
This finding suggest that the level of CLA-expression might be important for the
retention of allergen-specific T cells in the skin.
Chapter 7 evaluates the screening for food-specific sensitization using in vitro IgE
detection and skin prick-testing in infants and children. Results show a substantial
mismatch between the outcome of both tests when screening for food-specific
sensitization in infants and children with suspected food allergy. This indicates that
the screening for food-specific sensitization in the pediatric age group should be
performed using both in vitro IgE detection as well as skin prick testing, to prevent
false-negative results.
Chapter 8 provides a description of a new protocol for a double-blind, placebo-
controlled cow’s milk challenge (DBPCCMC) to diagnose immediate-type
hypersensitivity reactions in infants and children, in a normal pediatric clinical
setting. Results of the use of this protocol in a cohort of 154 children referred to the
pediatric outpatient clinic of the University Hospital in Utrecht showed that it is
possible to perform blinded-challenges routinely in the diagnostic work-up of
children with suspicion of CMA. This indicates that DBPCCMCs should be
implemented into routine pediatric practice, which may prevent inaccurate
diagnosis and unnecessary elimination diets.
Finally, Chapter 9 is a general discussion which summarizes and discusses the
presented data on CMP-specific T cells in this thesis. In this chapter, a model is
presented that describes the postnatal development of the T cell response to cow's
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milk in atopic and non-atopic individuals. Especially during infancy, clear
differences exist between the CMP-specific T cell response in atopic and non-
atopic individuals with regard to cytokine release. This suggests that the
mechanisms that regulate the T cell response to milk are of vital importance in the
development of clinical tolerance to CMPs. Future studies should therefore be
focused on the elucidation of these mechanisms, to give directions for the
development of therapeutic and preventive strategies in allergy to cow’s milk.
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SAMENVATTING
Allergie is een ziekte die een substantieel deel van de bevolking treft, en waarvan
die incidentie de afgelopen decennia fors is gestegen. Koemelkallergie (KMA) is
een van de belangrijkste voedselallergieen tijdens de zuigelingen- en peuterleeftijd.
Dit proefschrift gaat over patiënten met KMA en atopische dermatitis (AD), de
belangrijkste uitingsvorm van KMA tijdens de kinderleeftijd. Het doel van dit
proefschrift is om de rol van antigeenspecifieke T cellen bij het ontstaan van KMA
en AD te bestuderen. Verder worden enkele in-vivo en in-vitro methoden om KMA
te diagnosticeren geëvalueerd.
In Hoofdstuk 1 wordt een algemene inleiding op KMA en AD op de kinderleeftijd
gegeven. KMA speelt een pathogenetische rol in ongeveer eenderde van de
zuigelingen met AD tijdens het eerste levensjaar. Zuigelingen KMA ontwikkelen
spontaan klinische tolerantie voor koemelk (KM) binnen een relatief korte periode
van 1-3 jaar. Bij allergie voor inhalatieallergenen worden Th2 cellen, die grote
hoeveelheden van de cytokines: interleukine (IL)-4, IL-5 en IL-13 produceren, zeer
belangrijk geacht in het ontstaan van de allergische reacties. Op dezelfde manier
wordt T cel reactiviteit tegen de eiwitten in koemelk belangrijk geacht bij het
ontstaan van KMA, echter dit is tot nu toe nog niet goed onderzocht.
Hoofdstuk 2 beschrijft de verschillen tussen de KM-specifieke T cel respons in
bloed van zuigelingen met AD, met en zonder KMA. Met behulp van een
antigeenspecifiek kweeksysteem dat gebruik maakt van autologe B cellen, werden
KM-specifieke T cel klonen gekweekt uit bloed. De resultaten laten zien dat T
cellen, specifiek voor de eiwitten in koemelk, aanwezig zijn in het bloed van
zuigelingen met AD, onafhankelijk van het feit of ze KMA hebben. Analyse van de
cytokine productie laat zien dat deze cellen een ‘Th2-achtige’ cytokine productie
hebben; dwz een hoge productie van IL-4, IL-5 en IL-13. Zuigelingen zonder
KMA hebben daarentegen een respons die Th1-achtig is, dwz een hoge productie
van interferon (IFN)-γ en een lage productie van de Th2-cytokines.
In Hoofdstuk 3 worden zuigelingen onderzocht, die geen atopische predispositie,
en geen allergische ziekten hebben. De resultaten laten zien dat deze kinderen een
T cel respons hebben, gericht tegen de belangrijkste eiwitten in KM. Deze cellen
produceren een gebalanceerde, Th0-achtig cytokine patroon, dwz een gelijke
productie ‘Th1-‘ en ‘Th2-cytokines’. De vergelijking met de T cellen die
beschreven zijn in Hoofdstuk 2 benadrukt dit Th0-achtige cytokine patroon, en de
lage productie van de Th2-cytokines. Dit suggereert dat tolerantie voor melk in
normale personen niet veroorzaakt wordt door een afwezigheid van circulerende,
KM-specifieke T cellen,
maar, net als bij mensen met een atopische predispositie, waarschijnlijk
veroorzaakt wordt door de lage productie van Th2-cytokines door deze cellen.
Hoofdstuk 4 onderzoekt de veranderingen die optreden in de KM-specifieke T cel
respons tijdens de spontane ontwikkeling van tolerantie voor KM bij zuigelingen
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met KMA en AD. De resultaten laten zien dat KM-specifieke T cellen nog steeds
aanwezig zijn in het bloed van patiënten met KMA die klinisch tolerant geworden
zijn voor KM-eiwitten. De productie van de Th2-cytokines door deze cellen is
echter lager dan tijdens de (KM)allergische fase, terwijl de productie van IFN-γ is
gestegen. Dit resulteert in een Th1-achtig patroon. Deze resultaten benadrukken de
belangrijke rol van antigeenspecifieke (Th2) cytokine productie bij het ontstaan
van allergische reacties op KM-eiwitten.
In Hoofdstuk 5 wordt de expressie van verschillende celmembraaneiwitten op T
cellen onderzocht. De resultaten laten zien dat de expressie van de activatie-
‘markers’ CD25 en CD30 door KM-specifieke T cellen significant hoger is bij
zuigelingen met KMA, wat suggereert dat de activatiestatus van deze cellen hoger
is. Na het ontstaan van klinische tolerantie voor KM-eiwitten daalt de expressie
van deze activatie-‘markers’, wat suggereert dat de KM-specifieke T cel reactiviteit
afneemt. Vergelijking van de expressie van de membraan-eiwitten CD26 en CD30
met de productie van IL-4 en IFN-γ bevestigt eerdere studies die lieten zien dat, op
het niveau van de individuele T cel, de expressie van CD26 en CD30 niet gebruikt
kan worden om Th1- en Th2-cellen te onderscheiden.
In Hoofdstuk 6 worden KM-specifieke T cellen in bloed en huid onderzocht, en
vergeleken mbt de expressie van 'cutaneous lymphocyte antigen' (CLA), de
huidspecifieke 'homing-marker'. De resultaten laten zien dat de expressie van CLA
door KM-specifieke T cellen in bloed van patiënten met KMA en AD vergelijkbaar
is met T cellen van patiënten zonder KMA. Dit suggereert dat het vermogen van T
cellen in bloed van allergische en niet-allergische patiënten om specifiek naar de
huid te 'homen' niet essentieel verschillend is. De analyse van T cellen in de huid
van patiënten met AD laat echter zien dat expressie van CLA door deze cellen
significant hoger is dan T cellen in bloed van deze patiënten. Dit suggereert dat het
niveau van expressie van CLA belangrijk zou kunnen zijn voor het achterblijven
van allergeenspecifieke T cellen in de huid.
Hoofdstuk 7 evalueert de screening op voedsel-specifieke sensibilisatie mbv in
vitro IgE-detectie en huidprik testen bij zuigelingen en kinderen. De resultaten
laten een substantiële 'mismatch' zien tussen de uitkomst van beide testen bij het
screenen op voedsel-specifieke sensibilisatie bij zuigelingen en kinderen met de
verdenking op voedselallergie. Dit geeft aan dat de screening op voedsel-specifieke
sensibilisatie op de kinderleeftijd gedaan zou moeten worden gebruik makend van
beide testen, om foutnegatieve uitkomsten te voorkomen.
Hoofdstuk 8 beschrijft een nieuw protocol voor een dubbelblinde,
placebogecontroleerde koemelkprovocatie dat gebruikt kan worden om, in een
alledaagse pediatrische kliniek, 'immediate-type' allergische reacties op koemelk te
diagnosticeren bij zuigelingen en kinderen. De ervaringen met dit protocol, in een
cohort van 154 kinderen die verwezen werden naar de polikliniek voedselallergie
van het Universitair Medisch Centrum in Utrecht, laten zien dat het mogelijk is om
routinematig geblindeerde provocaties te verrichten bij kinderen met de verdenking
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op KMA. Dit suggereert dat dubbelblinde provocaties geïmplementeerd moeten
worden in de alledaagse pediatrische praktijk, wat inaccurate diagnostiek en
onnodige eliminatiediëten zou kunnen voorkomen.
Tot slot, Hoofdstuk 9 is een algemene discussie die de onderzoeksgegevens over
de KM-specifieke T cellen samenvat, en bediscussieert. In dit hoofdstuk wordt een
model gepresenteerd dat de postnatale ontwikkeling van de T cel respons tegen
koemelk in atopische en niet-atopische personen beschrijft. Met name op de
zuigelingenleeftijd zijn er duidelijke verschillen tussen de KM-specifieke T cel
respons van atopische en niet-atopische personen, vooral met betrekking tot
cytokine productie. Dit suggereert dat de mechanismen die de T cel respons tegen
melk reguleren zeer belangrijk zijn voor het ontstaan van klinische tolerantie voor
koemelkeiwitten. Toekomstige studies moeten daarom gericht worden op het
ophelderen van deze mechanismen. Dit kan richting geven aan de ontwikkeling van
therapeutische en preventieve strategieën voor allergie tegen koemelkeiwitten.
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DANKWOORD
Een proefschrift schrijven doe je niet alleen, daarom wil ik op deze plaats een
aantal mensen bedanken die mij de afgelopen 3 jaar op een of andere manier hierbij
hebben geholpen.
Prof.dr. C.A.F.M. Bruijnzeel-Koomen, beste Carla: jij hebt als promotor jouw
grote enthousiasme voor de (voedsel)allergie op mij over weten te brengen. Door
dit enthousiasme, en het feit dat ik altijd bij je aan kloppen voor advies, was het
niet moeilijk om dit proefschrift te voltooien. Het was een groot genoegen om jouw
promovendus te zijn.
Prof.dr. J.L.L. Kimpen, beste Jan: jou wil ik danken voor de mogelijkheid die je me
hebt geboden om in het Wilhelmina Kinderziekenhuis onderzoek te gaan doen.
Jouw kritische blik en vooral jouw snelheid van corrigeren van manuscripten
waren een goede stimulans tijdens deze gehele periode.
Edward Knol, jij hebt als copromotor vooral het laatste jaar erg veel geholpen bij
het schrijven van de verschillende artikelen en dit proefschrift als geheel. Jouw
enthousiasme voor alles wat met (allergie)onderzoek te maken heeft me daarbij
enorm geïnspireerd. Dank je wel hiervoor.
Enorm veel dank ben ik verschuldigd aan Els van Hoffen en Adrie van Ieperen,
zonder wie dit proefschrift voor een groot deel uit lege bladzijden had bestaan.
Els, jij hebt me heel goed begeleidt tijdens het analyseren en verwerken van de vele
gegevens die het onderzoek opleverden. Dat we daarnaast ook de gezelligheid niet
geschuwd hebben, heeft het voor mij extra leuk gemaakt om samen te werken. Ik
ben dan ook blij dat jij uiteindelijk als echte copromotor ook het voltooien van dit
proefschrift hebt kunnen begeleiden, en ik hoop dat je net zo trots bent op het
resultaat als ik.
Adrie, zonder jouw tomeloze inzet voor het kweekwerk, en de grote hoeveelheid
cytokine- en FACs-metingen die eruit voortvloeiden, kon dit onderzoek niet
worden gedaan. Ik ben je daarvoor erg dankbaar. Misschien zul je, net als ik, nog
wel eens met plezier terugdenken aan mijn gestuntel met de IL-2 Elisa.
Er is ook een aantal andere mensen dat geholpen heeft bij het in vitro-werk dat
beschreven is in dit proefschrift, en die ik daarvoor wil bedanken:
Coralien, ook al ben je inmiddels al weer een tijdje weg bij de afdeling
Dermatologie/Allergologie, jouw hulp bij vooral het vele FACs-werk was
onontbeerlijk voor dit proefschrift.
Machteld, dank voor het inspringen als het nodig was bij het labwerk, of op andere
momenten (FACs-artikel!), maar natuurlijk ook voor de gezelligheid rondom het
werk. Veel succes met jouw promotie!
Frank van Reijsen, de inspirator op de achtergrond. Je kunt trots zijn dat het door
jou opgestarte project weer tot een proefschrift over de rol van T cellen bij
allergische ziekten heeft geleid!
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Ik heb ook de mogelijkheid gehad om de klinische aspecten van voedselallergie
nader te onderzoeken. Hierbij ben ik geholpen door een groot aantal mensen:
Alle leden van de werkgroep 'Pediatrische Voedselallergie' wil ik bedanken voor de
prettige samenwerking gedurende de afgelopen jaren; Yolanda Meijer, Suzanne
Pasmans, Erik Wauters, André Knulst, Ems Carbasius Weber en Hanneke v/d
Bosch.
Ook de verschillende studenten die hebben meegewerkt bij dit onderzoek ben ik
dankbaar: Heike Nyst voor hulp bij de pilotstudies naar patch-testen en de
verlengde melk-provocatie, en Ingrid Pompen bij de kippenei-provocatie en de
verlengde melk-provocatie.
Alle artsen en verpleegkundigen van de afdeling 'Pauw', en alle medewerkers van
de polikliniek Algemene Kindergeneeskunde wil ik danken voor de prettige
samenwerking de afgelopen jaren, in het bijzonder Judith Witmond en Nicole
Löwenstein.
Zonder collega's zou het leven als onderzoeker erg eenzaam zijn. Daarom ben ik
erg blij dat ik zowel in het WKZ, als in het AZU geweldige collega's heb gehad.
Louis, Arieke, Yvette, Marijke, Nike en op de achtergrond Michiel en Jeanne-
Marie; dankzij jullie was het leven als onderzoeker op de 'flexkamer' naast hard
werken, vooral ook erg gezellig! Aan de lunches, en de bijbehorende discussies die
al dan niet over het werk gingen, zal ik dierbare herinneringen blijven houden. Ik
wens jullie veel succes toe bij jullie verdere onderzoek!
Ook mijn collega's bij de afdeling Dermatologie/Allergologie wil ik natuurlijk
bedanken. Annemarie, Arne, Bert, Diederik, Frank, Gerdien, Heggert, Ilse, Ines,
Kees, Marjolein, Marjan, Marloes, Niek, Rebecca, Stef, Susan, Wendy en alle
studenten die in het lab stage hebben gelopen; het koffie drinken en de labuitjes
waren altijd gezellig, ik zal ze zeker missen. Jantine, Marjan en Chantal, dank voor
jullie secretariële ondersteuning!
Alle mensen die de afgelopen jaren op het stafsecretariaat van de afdeling
Algemene Kindergeneeskunde hebben gewerkt wil ik bedanken voor de assistentie,
in het bijzonder Bea Batelaan. De perfecte computerondersteuning van Wim Fels
in het AZU, en de data-management-assistentie van Carla Tims waren ook zeer
belangrijk voor dit proefschrift.
Mijn paranimfen Bart en Louis, dank voor jullie hulp tijdens de laatste loodjes.
Ik wil op deze plek ook mijn ouders bedanken, aan wie ik dit proefschrift opdraag.
Jullie leerden mij nieuwsgierigheid en doorzettingsvermogen, twee eigenschappen
die onontbeerlijk zijn voor een onderzoeker. De liefde en steun die jullie mij gaven
maakten het mogelijk om dit proefschrift tot een goed einde te brengen. Hiervoor
ben ik jullie erg dankbaar.
Tenslotte Anke, jou hoef ik niets te zeggen, dank je wel.
Utrecht, september 2001
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Rogier Schade  werd geboren op 7 oktober 1971 in Nijmegen. Hij behaalde het
VWO diploma in 1989 aan het Titus Brandsma Lyceum in Oss. Hierna studeerde
hij gedurende 1 jaar elektrotechniek aan de Technische Universiteit in Eindhoven.
In 1990 begon hij met de studie Geneeskunde aan de Universiteit in Utrecht. Het
propedeutisch examen werd behaald in 1991 en het doctoraal examen in 1995.
Gedurende de studie geneeskunde verrichte hij onderzoek naar de prenatale
diagnostiek van  aangeboren hartafwijkingen en ritmestoornissen bij de afdeling
Cardiologie in het Wilhelmina Kinderziekenhuis in Utrecht onder begeleiding van
Dr. E.J. Meijboom. Ook was hij student-assistent bij de afdeling Anatomie in het
Academisch Ziekenhuis in Utrecht.  In 1996 werd begonnen met de co-
assistentschappen en het artsexamen werd behaald in 1998. In de laatste fase van
zijn co-schappen werkte hij gedurende 3 maanden als zaal-assistent op de afdeling
Pediatrie en Kindergesondheit in het  Tygerberg Hospitaal in Kaapstad, Zuid-Afrika
(hoofd: Prof.dr. P. Hesseling).
Met het onderzoek dat beschreven is in dit proefschrift werd aangevangen in juni
1998. Het onderzoek werd uitgevoerd bij de afdeling Dermatologie/Allergologie
(hoofd:  Prof.dr. C.A.F.M. Bruijnzeel-Koomen), en de afdeling Algemene
Kindergeneeskunde (hoofd: Prof.dr. J.L.L. Kimpen) van het Universitair Medisch
Centrum in Utrecht, onder begeleiding van Dr.  E. Knol en Dr. E. van Hoffen.
Per 1 januari 2002 zal hij beginnen met de opleiding tot kinderarts aan de afdeling
Kindergeneeskunde van het Leids Universitair Medisch Centrum (hoofd:
Prof.dr. J.M. Wit).
Rogier Schade is getrouwd met Anke Busch.
